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It is now accepted that increased antimicrobial re-
sistance (AMR) in bacteria affecting humans and an-
imals in recent decades is primarily influenced by an 
increase in usage of antimicrobials for a variety of 
purposes, including therapeutic and non-therapeu-
tic uses in animal production. Antimicrobial resist-
ance is an ancient and naturally occurring phenom-
enon in bacteria. But the use of antimicrobial drugs 
– in health care, agriculture or industrial settings 
– exerts a selection pressure which can favour the 
survival of resistant strains (or genes) over suscep-
tible ones, leading to a relative increase in resistant 
bacteria within microbial communities. It has been 
observed that, in countries where use of particular 
substances (e.g. fluoroquinolones) is banned in an-
imal production, there are low levels of resistance 
to these antimicrobials in livestock populations. The 
rate of AMR emergence in ecosystems such as the 
human or animal gut is likely to be highly depend-
ent on the quantity of antimicrobials used, along 
with the duration and frequency of exposure. In an-
imal production, the prolonged use of antimicrobial 
growth promoters (AGPs) at subtherapeutic levels in 
large groups of livestock is known to encourage re-
sistance emergence, and is still common practice in 
many countries today. Due to the interdependence 
and interconnectedness of epidemiological path-
ways between humans, animals and the environ-
ment, determining the relative importance of factors 
influencing AMR emergence and spread in animal 
production is a significant challenge, and is likely to 
remain one for some time.
In intensive livestock production systems, resist-
ant bacteria can spread easily between animals and 
this can be exacerbated if biosecurity is inadequate. 
While some studies have shown reduced levels of 
AMR on organic farms, a high prevalence of multid-
rug-resistant (MDR) Campylobacter strains has been 
detected in organic pig farms in the United States 
even in the absence of antimicrobial usage (AMU). 
In aquaculture, AMR can develop in aquatic and 
fish gut bacteria as a result of antimicrobial therapy 
or contamination of the aquatic environment with 
human or animal waste. The extent and persis-
tence of antimicrobial residues in aquatic systems 
is unknown and current evidence is conflicting.
Furthermore, no international guidelines currently 
exist for maximum antimicrobial residue limits in 
water. Water is an important vehicle for the spread 
of both antimicrobial residues and resistance de-
terminants, since contaminated water can be con-
sumed directly by humans and livestock and used 
to irrigate crops. 
Food is likely to be quantitatively the most im-
portant potential transmission pathway from live-
stock to humans, although direct evidence linking 
AMR emergence in humans to food consumption 
is lacking. There is a theoretical risk of widespread 
dissemination of AMR due to the increasingly global 
nature of food trade and human travel. This would 
mean that strains of resistant bacteria could now 
very quickly reach parts of the world where they had 
previously not been present. Agricultural systems in 
emerging economies such as China and India have 
changed radically in recent years, becoming increas-
ingly intensive in order to meet growing domestic 
and global demands for animal protein. This is like-
ly to heighten the occurrence and spread of infec-
tious diseases in these systems, thereby leading to 
increased AMU and therefore resistance. 
If the selection pressure resulting from AMU in an-
imals and humans were to be removed, this would 
still not completely halt the emergence and global 
spread of AMR due to the ability of AMR genes to 
move between bacteria, hosts and environments, 
and the occurrence of spontaneous mutations. 
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However, the release of large quantities of an-
timicrobials or resistant bacteria into the environ-
ment is still thought to be an important point for 
control, and therefore measures which encourage 
the prudent use of antimicrobials are likely to be 
extremely useful in reducing the emergence and 
spread of AMR. Future development of quickly bi-
odegradable antimicrobials could help to reduce 
environmental contamination, and pharmacody-
namic studies in livestock can be used to inform 
the optimization of AMU. Improved hygiene and 
biosecurity should be a major focus for all types 
of animal production systems so that the risks 
of introducing pathogens and resistance genes 
– and the spread of these within animal popula-
tions – can be reduced. Detailed, specific recom-
mendations for countries to move towards more 
prudent AMU in different agricultural settings 
are, however, beyond the scope of this paper.
An improved understanding of the epidemiology 
of AMR emergence and spread in animal produc-
tion will provide an essential foundation for suc-
cessful mitigation strategies. There are still consid-
erable gaps in our understanding of the complex 
mechanisms that lead to the emergence of AMR in 
bacteria, and the interactions that take place within 
microbial ecosystems enabling the transfer of resist-
ance between bacteria. There are insufficient data 
at present to determine quantitatively how impor-
tant the selection pressure of AMU is for the emer-
gence of AMR in bacteria. Evidence regarding AMR 
transmission pathways between food animals and 
humans is lacking, especially from low- and mid-
dle-income countries (LMICs). 
Such pathways are likely to be highly complex 
and multi-directional, especially in LMICs, but are 
still largely unknown. There remains little doubt, 
however, that the most significant factor in AMR 
emergence in humans is AMU for human treat-
ment and prevention. It is clear that both human 
and animal AMU can contribute to environmental 
contamination, although collection of meaningful 
data is challenging. The relationships between dif-
ferent types of farming systems and both AMU and 
the emergence and spread of AMR are discussed 
in this paper, including extensive and organic sys-
tems, but there is still a notable lack of knowledge 
on the role that sustainable agriculture systems can 
play in combatting AMR. Most importantly, future 
research needs to involve an interdisciplinary (e.g. 
One Health) approach, integrating agricultural, 
medical, environmental and social sciences, and 
especially recognizing the importance of human 
behaviour. A set of specific recommendations to 
fill current knowledge gaps is presented in the 
final section of this technical paper.
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Antimicrobial resistance (AMR)1 both in human and 
veterinary medicine has reached alarming levels in 
most parts of the world and has now been recog-
nized as a significant emerging threat to global pub-
lic health and food security. In June 2015, the Food 
and Agriculture Organization of the United Nations 
(FAO) passed a resolution on AMR at its governing 
Conference. This followed the adoption of counter-
part resolutions on AMR by The World Organisation 
for Animal Health (OIE) and the World Health Or-
ganization (WHO) in May 20152, and marked the 
beginning of a joint effort by the three organiza-
tions to combat AMR globally. The present technical 
paper was commissioned by FAO and is intended 
to inform a technical audience comprising scientists, 
policy-makers and stakeholders (including veterinar-
ians and medics) in FAO Member States. A review 
was undertaken of the available scientific literature, 
grey literature, reports, and other sources of evi-
dence, to examine the current state of knowledge 
on the relationship between animal production and 
AMR emergence and spread. The review methodol-
ogy is described in detail in Appendix 1.
Overuse of antimicrobials and improper use in 
many parts of the world are recognized as key drivers 
of the emergence and spread of AMR (Aminov and 
Mackie, 2007, APUA, 2008, Aarestrup et al., 2008, 
Acar and Moulin, 2012). Antimicrobials are used in 
food animals for treatment and for non-therapeu-
tic purposes, and play a critical role in saving lives 
in both humans and animals. Over the last decade, 
global livestock production has been growing rap-
idly and has moved increasingly towards industrial-
ized systems where antimicrobial use (AMU) is an 
integral part of production. It is projected that two 
thirds of the future growth of AMU will be for ani-
mal production (Van Boeckel et al., 2015). Although 
AMU in animals for growth promotion, prophylaxis 
and metaphylaxis (i.e. medicating mixed groups of 
healthy and infected animals in order to control out-
breaks of disease) has been substantially reduced in 
high-income countries in recent years, data availa-
ble indicate that livestock AMU will continue to in-
crease in low- and middle-income countries during 
the next decades due to the growing demand in 
LMICs for animal protein (Van Boeckel et al., 2015). 
Consequently, there is likely to be a commensu-
rate increase in resistance to commonly used antimi-
crobials in these countries and regions, which does 
not bode well for treatment and management of 
infections in both humans and animals. This is espe-
cially important for zoonotic pathogens but also for 
commensal bacteria as these can act as reservoirs 
for resistance genes within the gut microbiota and 
the environment (the “resistome”) (APUA, 2008). In-
deed, resistance to colistin, an antimicrobial used as 
a last resort for treating multidrug-resistant (MDR) 
infections in humans, was recently detected in an-
1 The term antimicrobial resistance (AMR) is used to refer to the ability of any microorganism (bacteria, viruses, parasites and fungi) to 
withstand the effect of one or more antimicrobial agents at clinically attainable concentrations, usually resulting in therapeutic failure. 
Throughout this document, AMR will be used to include resistance to antibacterial, antiviral and antiparasitic agents, although the focus 
will primarily be on bacterial resistance to antibacterial agents.
2 Details of all three resolutions on AMR are now available in the public domain: 
 FAO resolution: http://www.fao.org/3/a-mm736rev1e.pdf 
 OIE resolution: http://www.oie.int/en/about-us/key-texts/resolutions-and-recommendations/resolutions-adopted-by-the-oie-
international-committee/
 2015 WHO resolution: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_ACONF1Rev1-en.pdf
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imals, retail meat and humans in China and subse-
quently has been discovered in most world regions 
(Skov and Monnet, 2016). 
Despite the public health significance of, and 
global attention to, AMR, a number of important 
questions are still surrounded by significant uncer-
tainty, especially concerning the epidemiological re-
lationships between AMU and food animals, the oc-
currence of AMR in food animals and the exposure 
of humans to AMR via food products. This technical 
paper deals with the epidemiology of the emer-
gence of AMR as a consequence of AMU in animal 
production, and the risk of its spread via food distri-
bution and the environment. While this paper aims 
to take a global perspective, there are data gaps in 
certain regions of the world which means that some 
of the information presented has a European bias. 
The discussion begins with a technical description 
of the current state of knowledge regarding the ac-
quisition of AMR by bacteria, and types and mech-
anisms of resistance in bacteria. Subsequently, the 
influence of animal production on the emergence of 
AMR in animals and humans is discussed. This is fol-
lowed by an overview of local and global pathways 
of AMR transmission, and how these may be influ-
enced by different livestock production systems. 
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Antimicrobial resistance was first described in 1940 
in Bacillus coli (now known as Escherichia coli) by 
Abraham and Chain (1940), shortly before the start 
of the use of penicillin to treat infectious diseases 
in humans in the same year (Chain et al., 1940) 
and not long after its discovery by Fleming (1929). 
Since most antimicrobials in clinical use are natu-
rally produced by soil microorganisms, such micro-
organisms are the source of many resistance genes 
now found in clinically relevant bacteria, as was 
demonstrated more than 40 years ago (Benveniste 
and Davies, 1973). Further phylogenetic analysis 
has shed some light on the evolutionary origins of 
resistance, indicating that bacteria evolved AMR 
genes long before the ”antibiotic era” (Finley et 
al., 2013, Aminov and Mackie, 2007, Wellington et 
al., 2013, Martinez and Baquero, 2009), and even 
developed defences against synthetic compounds 
(D’Costa et al., 2011). There is growing evidence 
that AMR is in fact an ancient and natural part of 
the genome of environmental bacteria (Bhullar et 
al., 2012). However, it is important to realize that 
AMR was very rare in clinical isolates predating the 
introduction of antibiotics, as demonstrated in a 
retrospective analysis by Hughes and Datta (1983), 
which provides strong evidence for the central role 
of AMU in the emergence and spread of AMR as a 
public health threat. 
Evolution of resistance genes
In natural ecosystems, expression of AMR genes 
can act as a defence mechanism against antimi-
crobial- or toxin-producing competitors in the 
same ecological niche, or as a self-preservation 
mechanism in antimicrobial-producing bacteria 
(Martinez and Baquero, 2009, Courvalin, 2008). 
However, as the role of antimicrobials both in 
bacterial physiology and microbial ecology is mostly 
unknown – with theories ranging from the regula-
tion of cell growth mobilization (Amábile-Cuevas, 
1993, Davies and Davies, 2010) to environmental 
signalling (Yim et al., 2007) – the role and evolu-
tionary origins of AMR genes remain an educated 
guess. 
Bacteria that are able to metabolize antimi-
crobials and use these as a source of nutrients 
have been found to express multidrug resistance 
(APUA, 2008). It is likely that resistance genes 
and determinants from these bacteria can be 
transferred to other bacterial species, even tax-
onomically and genetically distant ones (Aminov 
and Mackie, 2007). Many resistance genes were 
originally used by bacteria to support vital meta-
bolic processes (Aminov and Mackie, 2007, Mar-
tinez and Baquero, 2009, Martinez, 2008). For 
example, some signalling molecules produced 
by environmental bacteria for communication 
purposes have been found to have antimicrobial 
activity (Martinez, 2008, Martinez and Baquero, 
2009).
β-lactamase enzymes encoded by plasmids in 
environmental bacteria may originally have been 
involved in synthesis of peptidoglycans rather 
than in providing resistance to β-lactam antimi-
crobials (Martinez and Baquero, 2009). Environ-
mental soil and water bacteria have been found 
to carry a pool of resistance genes (the “resi-
stome”) which can act as a reservoir of resistance 
for human pathogens (Forsberg et al., 2012, 
Lupo et al., 2012, APUA, 2008). 
Environmental changes – such as those induced 
by anthropogenic activities (e.g. use of antimicrobi-
als) – increasing human populations, urbanization, 
The emergence of antimicrobial 
resistance in bacteria
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lack of treatment of sewage and animal waste (Mar-
tinez, 2008), and the intensification of agriculture 
and industry, can affect the emergence of resistance 
in bacterial populations (IFT, 2006, Li et al., 2015). 
The transfer of resistance genes between humans, 
animals and the environment has recently been re-
ported in low-income population settings in Latin 
America (Pehrsson et al., 2016). Increased contact 
between human settlements, food-producing ani-
mals and wildlife has been reported as an important 
factor in the transfer of resistance traits and bac-
teria to species that usually would not be naturally 
exposed directly to selection pressure through anti-
microbial therapy (Cristobal-Azkarate et al., 2014, 
Österblad et al., 2001). Horizontal gene transfer 
(HGT) movements between farm environments, 
food, and human gut microbiota were estimated in 
one study to be composed of over 75 percent resist-
ance genes, but this was found also true for HGT 
episodes involving the human skin and oral system 
(Smillie et al., 2011). 
HGT movements were most likely to occur be-
tween phylogenetically diverse bacteria sharing 
the same ecological niche (e.g. human gut flo-
ra). The horizontal movement of genes can occur 
between Gram-negatives, Gram-positives and 
Actinobacteria; between aerobes and anaerobes; 
and between non-pathogenic and human-, ani-
mal- or plant-pathogenic bacteria (Amábile-Cue-
vas and Chicurel, 1992). For instance, glycopep-
tide-producing bacteria in the environment have 
been identified as a potential source of genes 
encoding vancomycin-resistance (van genes) to 
enterococci bacteria that can cause opportunistic 
disease in humans (i.e. vancomycin-resistant en-
terococci or VRE) (Courvalin, 2008). Enterococci 
can acquire, maintain and disseminate resistance 
genes to other enterococci and Gram-positive 
bacteria through mobile genetic units (e.g. trans-
posons, plasmids). In some instances, mobile ge-
netic units can account for up to 38 percent of 
the genome of enterococci (Werner et al., 2013). 
Furthermore, it has been observed that entero-
cocci of animal origin can also colonize the hu-
man gut (Werner et al., 2013). 
Therefore, dissemination of resistance genes can 
occur clonally, through vertical spread, and also via 
horizontal transfer through transposons and inte-
grons (intracellular gene mobilization) and through 
integrative and conjugative elements (ICEs, such 
as conjugative transposons) and plasmids, among 
others (Amábile-Cuevas, 2012, Courvalin, 2008).
Resistance genes acquired through horizontal 
transfer and mutations can provide bacteria with 
an evolutionary advantage in relation to other 
competitors in the same ecological niche, as long 
as the resistance does not result in a negative im-
pact on the bacteria’s physiology, also known as 
the “fitness cost” (Martinez and Baquero, 2009, 
Courvalin, 2008). A particular population of bac-
teria may lose resistance traits in the absence of 
selection pressure by antimicrobials (Courvalin, 
2008). However, acquired resistance genes may in-
directly provide an evolutionary advantage for the 
bacteria, even in the absence of selection pressure 
(Aminov and Mackie, 2007). A bacterium may also 
undergo further “compensatory mutations” that 
allow it to reduce the fitness cost of the acquired 
resistance genes (Aminov and Mackie, 2007, Berg-
strom and Feldgarden, 2007, IFT, 2006).
The presence of antimicrobials in the en-
vironment – as observed in hospitals or in-
tensive farm settings – has been associated 
with the survival of strains with higher rates 
of mutation (e.g. bacteria with hypermuta-
tor phenotypes) (Martinez and Baquero, 2009, 
Courvalin, 2008, Aminov and Mackie, 2007). 
Hypermutator phenotypes have been observed 
in chronic infections in humans (Martinez and 
Baquero, 2009). Gullberg et al. (2011) have ob-
served that very low concentrations of antimicro-
bials could enhance the survival of gene mutations 
in a bacterial population. Genetically, some bacteria 
have evolved to be diploids, which allows them to 
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express both susceptibility and resistant traits (Cour-
valin, 2008). Likewise, mechanisms that previously 
were used for other purposes (e.g. efflux pumps in 
cell membranes) can be adopted by bacteria – such 
as observed in resistant Escherichia coli strains (Web-
ber and Piddock, 2003) – in order to survive in an ad-
verse environment, even in the presence of semi-syn-
thetic or synthetic antimicrobials to which bacterial 
populations have not been previously exposed (e.g. 
fluoroquinolones) (Martinez and Baquero, 2009 
Aminov and Mackie, 2007, Courvalin, 2008). 
Types of resistance:  
intrinsic versus acquired
Bacteria can be naturally resistant to certain anti-
microbial groups or substances (Prescott, 2008) 
(intrinsic resistance), or they can obtain resistance 
to antimicrobials through a variety of mechanisms, 
such as mutation (acquired resistance).
A brief overview of intrinsic and acquired resistance 
mechanisms is given in Table 1 and discussed below.
 
Intrinsic resistance
Intrinsic resistance is mediated by chromosom-
al genes (Alekshun and Levy, 2007, Courvalin, 
2008) and is usually linked to physiological or 
anatomical characteristics of the bacteria (IFT, 
2006), hence it is usually a trait shared by all 
organisms within the same genus or species 
(Courvalin, 2008). Resistance to penicillin G 
expressed by most Gram-negative bacteria is 
a common example (Boerlin and White, 2013, 
SCENIHR, 2009), this is due to the complexity 
of its cell wall with the presence of an outer 
membrane – absent in Gram-positive bacteria 
(IFT, 2006). 
Acquired resistance 
Vertical transmission. Chromosomal mutations 
are extremely rare (i.e. 10-7 to 10-9 frequency), but 
are very relevant to the development of resistance 
in bacterial clones (Courvalin, 2008) (Table 1). Mu-
tations can either affect target or regulatory genes 
(Courvalin, 2008). Target mutations occur in struc-
tural genes that encode the specific targets of anti-
microbial action (Courvalin, 2008).
Single point mutations are the most commonly 
observed once an antimicrobial substance is intro-
duced (Bergstrom and Feldgarden, 2007), such as 
that observed with quinolone and macrolide resist-
ance in Campylobacter spp. (Aarestrup et al., 2008, 
Moore et al., 2006, Cambau and Guillard, 2012).
Regulatory mutations usually affect gene ex-
pression mechanisms and are difficult to predict as 
they can occur spontaneously (Courvalin, 2008). 
Table 1. types of resistance observed in bacteria
Intrinsic resistance Acquired resistance 
Definition •	 Natural traits
•	 Species or genus specific
•	 A strain that develops resistance to an antimicrobial  
to which it was previously susceptible
•	 Present only in certain strains of a species or genus
Mechanisms  
of resistance
acquisition
•	 Inherent structural or functional  
characteristics of the bacteria  
that allow it to tolerate or be insensitive  
to an antimicrobial substance or class 
Vertical transmission
•	 Spontaneous gene mutation
•	 Induced gene mutation
 
Horizontal gene mutation
•	 Bacterial transformation
•	 Bacterial transduction
•	 Bacterial conjugation
Source: Boerlin and White, 2013
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Unspecific efflux pumps, encoded at chromosom-
al level and therefore genus-specific, can confer 
multidrug resistance to unrelated antimicrobial 
substances (Courvalin, 2008, Demple and Amá-
bile-Cuevas, 2003).
Horizontal transmission. When genes from a cell 
are transferred into another cell, independently of 
a reproductive event, this is known as “horizontal 
gene transfer” (HGT) (Table 1). HGT occurs through 
three main mechanisms: (a) transformation, the 
uptake of free DNA by a “competent” bacterial 
cell; (b) transduction, the mobilization of bacterial 
DNA from one bacterial cell to another by a bac-
teriophage (i.e. a virus); and (c) conjugation, the 
mobilization of DNA from a donor bacterium to a 
recipient bacterium, requiring physical contact and 
conjugative machinery (Amábile-Cuevas and Chi-
curel, 1992, Amábile-Cuevas, 2012).
HGT is probably the most relevant mode of re-
sistance emergence and spread in bacterial popu-
lations (Aarestrup et al., 2008). Horizontal passage 
of resistance can arise through the transfer of sin-
gle resistance determinants or of combinations of 
genes inserted in mobile structures: gene cassettes 
incorporated into integrons, which can be incorpo-
rated into transposons, and transposons which can 
be integrated into plasmids (Martinez and Baque-
ro, 2009, Amábile-Cuevas and Chicurel, 1992). In-
tegration and transposition allows the intracellular 
movement of genes, gathering several resistance 
determinants into a single genetic element, and also 
rearranging genes to modify their expression (Amá-
bile-Cuevas, 2012, Mathew et al., 2007, Levy and 
Marshall, 2004, Mazel, 2004). Integrons were ini-
tially identified in Gram-negative bacteria but have 
also been detected in Gram-positives (Levy and Mar-
shall, 2004). Class I integrons are commonly associ-
ated with resistance and found in isolates from live-
stock (Mathew et al., 2007), the presence of class 
I integrons in Escherichia coli is very dependent on 
selection pressures of human origin (Díaz-Mejía et 
al., 2008), showing that antimicrobial pressure does 
not only select for AMR traits, but also for mecha-
nisms of mobilization. Transposons, in turn, facilitate 
the transfer of genetic material within the same or 
different DNA molecules or even between different 
organisms as ICEs, as previously described (Martínez 
et al., 2007). Plasmids are DNA structures that can 
be transmitted horizontally and/or vertically through 
bacterial clones (Martinez and Baquero, 2009). 
However, not all mobile modular units are effective-
ly transferred or expressed between bacteria (Aare-
strup et al., 2008). For instance, some Gram-positive 
bacteria are not able to express genes transferred 
from Gram-negative bacteria (Courvalin, 2008).
Gathering of resistance genes in a single genet-
ic element enables the co-selection of resistance 
by unrelated antimicrobials leading to multidrug 
resistance, and even potentially by non-antimicro-
bial compounds such as metal ions and biocides. 
Also, the assembly of plasmids enables the acqui-
sition of resistance to several unrelated antimicro-
bials through a single event, such as conjugation. 
Finally, resistance genes are often found along with 
virulence traits in the same genetic element, making 
the bearer of such an element an enhanced, mul-
tidrug-resistant pathogen (Amábile-Cuevas, 2003).
 
Adaptive resistance
A number of regulated responses to environmen-
tal stress can activate AMR phenotypes by means 
of active efflux and/or diminished permeability. 
Among the best characterized of these responses 
are the marRAB regulon and the soxRS regulon.
Both were first described in Escherichia coli but 
there are equivalent systems in many Gram-nega-
tive bacteria (Demple and Amábile-Cuevas, 2003). 
Activating agents include a variety of compounds, 
ranging from antimicrobials to non-antibacteri-
al drugs (e.g. phenazopyridine) (Amábile-Cuevas 
and Arredondo-García, 2013), and herbicides (e.g. 
glyphosate) (Kurenbach et al., 2015). Resistance to 
antimicrobials achieved through these mechanisms 
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disappears when the stimulus is gone and is thus 
distinct from intrinsic resistance. Single mutations 
in regulatory genes can cause a permanent overex-
pression of the whole regulon, hence turning the 
mutant into a full-resistance phenotype. Howev-
er, there is no evidence for such mutations having 
been horizontally mobilized, confining this kind of 
acquired resistance to vertical inheritance.
Mechanisms of bacterial 
resistance 
There are a number of mechanisms that render a bac-
terial cell resistant to one or several antimicrobials. 
These mechanisms can be organized into five 
broad categories: (1) decreased accumulation of 
the antimicrobial within the cell, either through 
diminished permeability and/or active efflux of the 
antimicrobial from the bacterial cell; (2) enzymatic 
modification or degradation of the antimicrobial; 
(3) acquisition of alternative metabolic pathways to 
those inhibited by the antimicrobial; (4) modifica-
tion or protection of the antimicrobial target; and 
(5) overproduction of the target enzyme (van Hoek 
et al., 2011). The cellular targets of antibiotics, and 
bacterial resistance mechanisms to main antimicro-
bial groups, are shown in Figure 1. A brief summary 
of acquired resistance mechanisms for different anti-
microbial groups is provided in Appendix 2.
Multidrug resistance
A bacterial cell can achieve resistance to multiple, 
unrelated antimicrobials, by means of a single mu-
tation. Such mutations often involve decreased 
Cell Wall
ß-lactams
Vancomycin
ANTIBIOTIC TARGETS ANTIBIOTIC RESISTANCE
DNA/RNA Synthesis
Fluoroquinolones
Rifamycins
Folate Synthesis
Trimethoprim
Sulfonamides
Cell Membrane
Daptomycin
Protein Synthesis
Linezolid
Tetracyclines
Macrolides
Aminoglycosides
Inactivating Enzymes
ß-lactams
Aminoglycosides
Macrolides
Rifamycins
Target Modification
Fluoroquinolones
Rifamycins
Vancomycin
Penicillinis
Macrolides
Aminoglycosides
Immunity & Bypass
Tetracyclines
Trimethoprim
Sulfonamides
Vancomycin
Efflux
Fluoroquinolones
Aminooglycosides
Tetracyclines
ß-lactams
Macrolides
FIGURE 1. Antibiotic targets and mechanisms of resistance
Source: Wright, 2010
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accumulation of antimicrobials in the cell, either 
by decreased permeability (e.g. reduction in the 
number and/or pore size of outer membrane por-
ins (Omps) in Gram-negative bacteria), and/or in-
creased efflux through unspecific pumps (e.g. Acr-
AB in enteric bacteria, Mex in Pseudomonas spp.).
Other biocides and toxic agents
A number of genes encoding resistance to non-an-
timicrobial agents have been found linked to AMR 
genes in single genetic elements, fostering co-se-
lection. For instance, mercury-resistance genes mer 
(encoding transport systems, reductase enzymes and 
even lyase enzyme to detach mercury from organo-
mercurial compounds) are commonly found along 
with AMR genes in the Gram-negative transposon 
Tn21, which also harbours an integron and staph-
ylococcal resistance plasmids. Likewise, qac genes 
mediating resistance to quaternary-ammonium disin-
fectants – commonly used in hospital and agriculture 
settings – through active efflux, are found in the con-
served region of class I integrons (Liebert et al., 1999).
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There is a substantial body of evidence to support 
the view that the emergence of antimicrobial re-
sistance in bacteria in livestock populations is con-
nected to the emergence of AMR in bacterial pop-
ulations that colonize and infect humans (Singer et 
al., 2003, ECDC/EFSA/EMA, 2015, O’Neill, 2015). 
For example, a recent systematic review found that 
“a proportion of human extra-intestinal expand-
ed-spectrum cephalosporin-resistant Escherichia coli 
(ESCR-EC) infections originate from food- producing 
animals”, with poultry as a probable source (Lazarus 
et al., 2015). 
Despite this, other recent studies claim that most 
of the emergence of AMR in bacteria in humans ap-
pears to originate from AMU in humans, while the 
majority of AMR bacteria in livestock seem to orig-
inate from AMU in livestock. For example, phyloge-
netic and whole genome sequence analysis of Salmo-
nella enterica serovar Typhimurium DT104 in human 
and livestock populations in Scotland has shown a 
greater diversity of AMR genes in human S. Typhi-
murium DT104, by comparison with those isolated 
in local livestock populations. The implication is that 
there were contributing sources other than foods of 
animal origin or livestock (Mather et al., 2013). Stud-
ies based on the phenotypes of AMR bacterial pop-
ulations have yielded similar conclusions (Mather et 
al., 2012). In addition, a recent systematic review re-
ported that usage of antimicrobials of critical impor-
tance for human treatment (such as fluoroquinolo-
nes and third- and fourth-generation cephalosporins) 
was higher in humans than in food-producing an-
imals after adjusting by biomass (ECDC/EFSA/EMA, 
2015). In most cases, in both animals and humans, 
a positive association was found between the vol-
ume of antimicrobial consumption and prevalence 
of resistance in the exposed bacterial populations. 
Nevertheless, there is consensus within the scientific 
literature that there are routes for spillover of AMR 
between the bacterial populations of humans and 
food-producing animals in both directions. The most 
commonly mentioned route is via AMR bacteria (and 
genetic material) passed through food distribution 
and consumption, the majority of which are colo-
nists of the host gastrointestinal tract (Lazarus et al., 
2015). Such bacteria may be commensal in animals 
but pathogenic in humans, or may be commensal in 
both, but may later convey resistance to food-borne 
pathogens in the human gut (Singer et al., 2003). In 
general, the repercussions of such crossover events, 
in terms of human disease, appear to be exhibited in 
outbreak form (Mather et al., 2013), though this ap-
parent pattern may be a result of reporting bias, as a 
result of a relatively high abundance of research into 
this route and evidence generated through govern-
ment-led outbreak investigations. Strong and direct 
evidence for AMR transmission via food is still limited 
(Lazarus et al., 2015). For instance, a study in The 
Netherlands reported increased levels of ESBL (ex-
tended spectrum beta-lactamase) enzyme-produc-
ing bacterial isolates with similar resistance genes in 
poultry meat and humans (Overdevest et al., 2011). 
Further, there is evidence of AMR occurrence not 
only in animal-derived foodstuffs (Raufu et al., 2014, 
Dipeolu and Alonge 2002, Muriuki et al., 2001, Ka-
riuki et al., 2013, NARMS, 2013, ECDC/EFSA/EMA, 
2015, Duong et al., 2006, Thai et al., 2012) but also 
in vegetables (de Vasconcelos Byrne et al., 2016, 
Kim et al., 2015, McGowan et al., 2006). The re-
cent detection of resistance to colistin in food-borne 
pathogens in humans, livestock, meat and vegeta-
bles across different countries raises the issue of the 
The relevance of animal 
production in the emergence 
of antimicrobial resistance
Drivers, Dynamics anD epiDemiology of antimicrobial resistance in animal production
10
Bacterial 
species 
Antimicrobial 
resistance 
pattern
Infections  
commonly 
observed 
in humans 
Animal 
sources 
of human 
infection
Other known 
sources
of human 
infection
Campylobacter spp. Fluoroquinolones Gastrointestinal  
(sequelae: 
Guillain-Barré syndrome)
Food-producing 
animals (poultry)
Raw  
unpasteurized milk, 
water
Enterococcus spp. Aminoglycosides 
Ampicillin  
Vancomycin
Food-producing 
animals (poultry)
Escherichia coli Quinolones  
Sulphonamides 
Trimethoprim
Gastrointestinal,  
UTI, HUS
LA-MRSA Food-producing 
animals (pigs, 
calves, cows)
Salmonella spp. 
(non-typhoidal)
Cephalosporins 
Quinolones  
Tetracyclines
Gastrointestinal Food-producing 
animals (pigs, 
cows, poultry)
Legend: HUS - Hemolytic Uremic Syndrome, LA-MRSA - Large Animal Methicillin-resistant Staphylococcus aureus, UTI - Urinary Tract Infection
Source: Adapted from Furuya and Lowy (2006)
potential role of global travel and trade in the trans-
boundary dissemination of resistance genes (Skov 
and Monnet, 2016, Doumith et al., 2016, Liu et al., 
2016, Kluytmans–van den Bergh et al., 2016, Zurfuh 
et al., 2016).
Some of the resistant bacterial populations docu-
mented, which are of importance to human health, are 
shown in Table 2. This is not an exhaustive list.
Drivers of AMR emergence  
in animal production
Although antimicrobial resistance occurs primarily 
as a consequence of selection pressure placed on 
susceptible microbes by the use of antimicrobial 
agents (Dione et al., 2009, Glynn et al., 2004, Grace 
et al., 2008, Koningstein et al., 2010), a variety of 
other factors also contribute to the emergence and 
spread of resistance. This section will specifically fo-
cus on factors driving AMR in agriculture.
Measures such as vaccination, limited co-min-
gling, adequate ventilation and temperature con-
trols, biosecurity, appropriate nutrition and housing, 
and quality-assurance programmes are commonly 
used in modern animal production to reduce the risk 
of introduction and spread of infections in herds. But 
it must be recognized that these risk-management 
practices usually require substantial financial invest-
ment, as well as training and incentivizing staff. Even 
if these measures are implemented properly, howev-
er, a residual disease risk will remain (Adelaide et al., 
2008, Cerniglia and Kotarski, 2005, Kariuki et al., 
2013). Consequently, antimicrobials are commonly 
used non-therapeutically in livestock production 
as a kind of “insurance” in addition to other ani-
mal disease risk-management measures.
Resistance to tetracycline, penicillins and sul-
phonamides has been commonly observed among 
chicken and swine bacterial isolates, and MDR 
has been reported as significantly higher in these 
isolates than those from cattle. The intensive con-
ditions under which pigs and chickens are often 
housed may be associated with greater disease 
potential and therefore a greater AMU in order to 
Table 2. sources of antimicrobial resistance (bacteria and bacterial genes) in animal 
production settings
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control sub-clinical infections (Duff and Galyean, 
2007). In some non-European countries, antimi-
crobials are widely used by farmers without veteri-
nary supervision due to their relatively low cost and 
ready availability for sale over the counter (Laxm-
inarayan et al., 2013). In Kenya, tetracyclines ac-
count for 55 percent of the antimicrobials used in 
food animals (Mitema et al., 2001).
 In another study in Kenya by Kariuki et al. (2013), 
oxytetracycline was the most commonly used among 
small-scale poultry farmers, while other antimicro-
bials used included fluoroquinolones (norfloxacin 
and enrofloxacin), erythromycin, sulphonamides and 
co-trimoxazole. Antimicrobials were readily available 
and mostly purchased over the counter or from ani-
mal health assistants, without resorting to veterinary 
advice. Drug quality was identified as an issue, as ap-
proximately one third of the drugs failed quality tests 
carried out by the National Quality Control Laborato-
ry. In the same study, overall AMR among the path-
ogens and indicators tested was highest in poultry 
isolates, followed by those from pigs and cattle. This 
probably reflects the more intensive nature of poultry 
farming and higher levels of AMU observed. 
Enteric bacterial isolates detected in food-produc-
ing animals and meat were commonly resistant to 
ampicillin, tetracycline, co-trimoxazole and strepto-
mycin. The range of types of resistance observed was 
broader among poultry and chicken meat isolates, 
with notable additional resistance to quinolones and 
third-generation cephalosporins, which are critically 
important in human medicine. There was a trend for 
increased AMR prevalence and MDR among isolates 
from commercial abattoirs sourcing chickens from 
medium- and large-scale commercial farms. Tetracy-
cline resistance was most common along meat value 
chains beginning with small-scale farms, correlating 
with farmers commonly reporting its use. Increased 
contamination and differences in AMR patterns were 
observed between isolates from beef carcasses at the 
abattoir and those from retail beef in some supply 
chains, suggesting the possibility of contamination at 
a later stage during the value chain in that setting. 
A noteworthy observation from this study was that 
the AMR patterns of E. coli isolated from children 
under five years of age at outpatient clinics in the 
meat value chain study areas reflected the common-
ly used antimicrobials in human medicine, including 
ampicillin, co-trimoxazole, streptomycin and amoxi-
cillin-clavulanic acid, with lower levels of resistance 
to third-generation cephalosporins and ciprofloxacin. 
This suggests that contaminated meat may be just 
one exposure pathway for humans. The findings em-
phasize the need for further work to better define 
such pathways and their relative importance, and the 
potential for targeted risk management. Neverthe-
less, food is likely to still be an important vehicle for 
transmission of resistant bacteria from animals to hu-
mans. Additional factors that can drive AMR include 
environmental contamination with excreted antimi-
crobials or their metabolites, residue concentrations 
of antimicrobials in edible tissues, and direct zoonot-
ic transmission (Pruden and Arabi, 2011, Marshall 
and Levy, 2011, Padungtod et al., 2006, Aarestrup, 
2006, O’Neill, 2016).
The loss of effective antimicrobials to treat sick 
animals adversely affects livestock production and 
farmers’ livelihoods (Cerniglia and Kotarski, 2005). 
An additional risk for anyone involved in the meat 
production chain is exposure to resistant bacteria. 
For example, farmers working with cattle, pigs 
and poultry are more likely to be infected with me-
thicillin-resistant Staphylococcus aureus (MRSA-398) 
than other individuals in the community (Garcia-Al-
varez et al., 2012, Lewis et al., 2008).
Categories of AMU in animal 
production in relation  
to the emergence of AMR 
Antimicrobial Use
Widespread antimicrobial use is considered to be the 
main factor associated with resistance in bacterial 
populations (APUA, 2008, Aarestrup et al., 2008, 
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Acar and Moulin, 2012). The use of antimicrobials 
in health care, agriculture, horticulture, aquaculture 
and industrial settings has an impact on the expres-
sion, selection, persistence and transfer of resistance 
traits in bacterial populations (Aminov and Mackie, 
2007, Courvalin, 2008, Mathew et al., 2007, PCIFAP, 
2010). Excessive use and misuse of antimicrobials are 
widely recognized as two of the major drivers for ac-
quired AMR, both directly and indirectly, due to the 
selection pressure imposed on human and animal 
microbiota (WHO, 2014a, Novo et al., 2013, PHE, 
2014), and on environmental bacteria (Martinez and 
Baquero, 2009). Many of the antimicrobial substanc-
es licensed for veterinary use belong to antimicrobial 
classes or groups routinely used in humans. Table 3 
provides an example of those licensed for use in an-
imals in the EU.
Usage of third-generation cephalosporins (e.g. 
ceftiofur), deemed as critically important antimicro-
bials in humans (WHO, 2012), has been associated 
with the selection of co-resistance to disparate an-
timicrobials such as tetracycline and chloramphen-
icol in enteric Escherichia coli bacteria (Lowrance 
et al., 2007). This has been observed in hospitals, 
farms, wastewater and sewage environments and 
in the gut of treated animals and humans (Martin-
ez and Baquero, 2009, APUA, 2008). The persis-
tence of antimicrobial residues in feed and animal 
waste contaminating soil and water also affects the 
aquatic and environmental microbiomes (You and 
Silbergeld, 2014). Colistin (polymyxin E) has been 
used in veterinary medicine for several decades, 
and is used across different food-producing ani-
mal species (e.g. pigs, poultry, sheep, goats, calves 
and adult cattle) including farmed fish. Indications 
for usage range from gastrointestinal infections by 
Gram-negative bacteria to topical treatment of mas-
titis, colistin is often supplied in feed and water in 
intensive systems, not only for treatment purposes 
but also for prophylactic and metaphylactic purpos-
es in groups of animals (Catry et al., 2015, EMA, 
2015). Colistin is also currently used in human med-
icine for the treatment of infections caused by MDR 
carbapenem-resistant Gram-negative bacteria, in 
combination with tigecycline, which has led colistin 
to be reclassified as a highly important antimicrobi-
al by WHO (Catry et al., 2015, EMA, 2015, WHO, 
2012). The recent detection of acquired colistin re-
sistance in food-borne pathogens in animals, foods 
and humans (associated with infection), observed 
across several countries, raises serious and urgent 
public health concerns (Figures 2 and 3) (Skov and 
Monnet, 2016). It is currently recommended that, 
for veterinary purposes, colistin should only be used 
for treatment (Catry et al., 2015, EMA, 2015). 
However, there are currently limited data on the 
extent and patterns of antimicrobial usage observed 
in food-producing animals, particularly in LMICs.
Only a few countries in Europe (e.g. the Nether-
lands, Denmark, Sweden) currently conduct inte-
grated surveillance of AMU and AMR in humans, 
animals and food products of animal origin. At Eu-
ropean level, the ESVAC (European Surveillance of 
Veterinary Antimicrobial Consumption) programme 
assesses antimicrobial sales, adjusted by biomass 
of livestock populations, across different Europe-
an countries (ESVAC, 2015). A recent study by Van 
Boeckel et al. (2015) used statistical models based 
on the data from 32 countries to estimate the extent 
of antimicrobial usage in food-producing animals at 
global level (Figure 4).
The emergence of AMR strains is dependent on 
several factors relating to the antimicrobial itself 
(e.g. amount, dosage, frequency and duration of 
selection pressure) and the organism (e.g. presence 
of genes conferring resistance to that particular sub-
stance, and advantage provided by the expression 
of these to the survival of the bacteria) (McEwen, 
2006). Use of antimicrobials may unblock gene ex-
pression, resulting in the development of resistance 
genes in bacteria (Courvalin, 2008, Lambert, 2012) 
or promoting the occurrence of mutations (Martínez 
et al., 2007). This kind of selection pressure is an 
important factor in the dissemination of resistance 
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Antimicrobial 
class
Veterinary
use in 
the EU
Major 
indications 
Risk to 
public 
health
Hazard of 
zoonotic 
relevance
Probability 
of AMR 
transfer
Aminoglycosides 
(e.g. gentamicin, 
neomycin)
Species: cattle, sheep, 
goats, horses, dogs 
and cats
•	 Septicaemias
•	 Digestive, respiratory  
and urinary infections
Risk profiling 
required
Enterobacteriaceae
Enterococcus spp.
High
Cephalosporins 
(3rd and 4th generation)
Species: cattle, pigs, 
horses, dogs and cats 
•	 Septicaemias
•	 Respiratory infections
•	 Mastitis
High Enterobacteriaceae High
(Fluoro) quinolones Species: cattle, pigs, 
chickens, turkeys,
rabbits, dogs and cats
•	 Septicaemias
•	 Infections (e.g. colibacillosis)
High Campylobacter spp.
Enterobacteriaceae
High
Macrolides  
(including ketolides)
Species: cattle, sheep, 
pigs, and poultry
•	 Mycoplasma infections  
(pigs and poultry)
•	 Haemorrhagic digestive 
disease and prolifera-
tive enteropathies (leitis) 
associated with Lawsonia 
intracellularis (pigs)
•	 Respiratory infections 
•	 (cattle and sheep)
•	 Liver abscesses (cattle)
Low to limited Campylobacter spp.
Salmonella spp.
High
Penicillins  
(natural- 
Lactamase- sensitive)
Species: cattle, sheep, 
poultry, horses, dogs 
and cats
•	 Septicaemias
•	 Respiratory infections
•	 Mastitis
Low or limited None specific High
Penicillins (broad 
spectrum beta-
lactamase-sensitive)  
Aminopenicillins 
Species: cattle, sheep, 
pigs, poultry and dogs
•	 Pasteurellosis and  
colibacillosis (poultry)
•	 Streptococcus suis  
infections (pigs)
•	 Respiratory infections  
(cattle and pigs)
Further risk  
profiling 
required
Enterobacteriaceae
Enterococcus spp.
High
Penicillins (narrow 
spectrum beta-
lactamase resistant)
Species: cattle and sheep •	 Metritis
•	 Mastitis
Low or limited None specific High
Penicillins (Beta-
lactamase protected 
broad spectrum) - 
Co-amoxiclav
Species: cattle, pigs,
dogs and cats 
•	 Respiratory infections
•	 Mastitis 
•	 Metritis
•	 Colibacillosis (cattle and pigs)
Further risk 
profiling  
required
Enterobacteriaceae
Enterococcus spp.
High
Polymyxins 
(including  
colistin or 
polymyxin E)
Species: cattle, sheep, 
pigs and poultry
•	 Septicaemias
•	 Colibacillosis
•	 Urinary infections
•	 Gram-negative  
digestive infections 
Currently  
under  
evaluation
Enterobacteriaceae Low*
Rifamycin (rifampicin) Species: cattle •	 Mastitis
•	 Metritis
Low or limited None specific High
Tetracyclines Species: cattle, sheep, 
goats, pigs, horses  
and poultry
•	 Respiratory diseases
•	 Bacterial enteritis
•	 Urinary tract infections
•	 Metritis
•	 Mastitis
•	 Pyodermatitis
•	 Keratoconjutivitis (cattle)
•	 Chlamydiosis
•	 Heartwater
•	 Anaplasmosis
•	 Actinomycosis
•	 Actinobacilosis
•	 Ehrlichiosis
•	 Resistant strains  
of Staphylococcus aureus
Low or limited Brucella spp. High
*May need to be reassessed in the light of new evidence of the emergence of plasmid-mediated colistin resistance in animals and humans 
(Catry et al., 2015, Skov et al., 2016).
Source: Adapted from EMA, 2014
Table 3. List of antimicrobial classes licensed for veterinary use in the eU and main indications
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Figure 3. geographical distribution of detected colistin resistance (mcr-1 gene)  
in humans as of March 2016
Figure 2. geographical distribution of detected colistin resistance (mcr-1 gene)  
in food-producing animals as of March 2016
Source: Skov and Monnet, 2016
Source: Skov and Monnet, 2016
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Figure 4. estimated antimicrobial consumption in food-producing animals at global level  
in milligrams per 10 km2 pixel (top map), and average standard deviation (sD) of estimates  
of milligrams per PcU (Population correction Factor), a technical unit of measurement  
which acts as a proxy for the size of the animal population (bottom map)
Source: Van Boeckel et al., 2015
determinants (Courvalin, 2008). Antimicrobials as 
disparate as fluoroquinolones and β-lactams may 
even foster the intra- and inter-cellular mobilization 
of resistance genes (Amábile-Cuevas, 2012). Pro-
longed antimicrobial exposure has been associated 
with acquisition of multidrug resistance in enter-
ic bacteria in both humans and animals (Levy and 
Marshall, 2004), and also in aquaculture (Nonaka et 
al., 2007). The use of combinations of antimicrobi-
als may also result in the selection of MDR bacterial 
strains (Martinez and Baquero, 2009). Use of oral 
systemic antimicrobials in groups of animals is com-
mon practice in conventional farms, particularly in 
pigs (Burow et al., 2014) and poultry (Apata, 2009).
 This places selection pressure on both commen-
sal and pathogenic bacteria in the gut flora, which 
promotes the exchange of genetic material (Cour-
valin, 2008, Burow et al., 2014). Antimicrobial 
usage is particularly high in monogastric species 
(poultry and pigs), compared to other food-pro-
ducing animals. 
These are typically kept in intensive, indoor pro-
duction systems at high densities, and are there-
fore vulnerable to infectious disease challenges 
(McEwan and Fedorka-Cray, 2002, O’Neill, 2016). 
In monogastric production systems, the dosage, 
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frequency and duration of antimicrobial therapy is 
likely to be high. Since it has been estimated that 
75 to 90 percent of antimicrobials used in livestock 
are excreted, mostly unmetabolized (Marshall and 
Levy, 2011), the concentration of antimicrobial 
residues in these farm environments is likely to be 
high. This is a crucial risk factor for the emergence 
of AMR.
AMU also impacts on the competition for nutri-
ents between bacterial populations in ecosystems 
through the elimination of susceptible bacteria 
(Aarestrup et al., 2008). In a recent simulation 
model by Volkova et al. (2013), plasmid-mediated 
resistance to ceftiofur in Escherichia coli in live-
stock was affected by the reduction of numbers 
of susceptible bacteria in the gut microbiota. Use 
of antimicrobials also appears to reduce the infec-
tive dose required by resistant pathogens to cause 
infection, posing a serious risk for hosts colonized 
with, or exposed to, these bacteria (da Costa et al., 
2013). Although there is evidence of occurrence of 
resistance in gut commensal bacteria (e.g. Escher-
ichia coli, Enterococcus spp.) in food-producing 
animals and foods of animal origin (Chantziaras et 
al., 2014), there are currently scarce data on the 
role of these bacteria as potential sources of re-
sistance genes for human and animal pathogens 
(Courvalin, 2008).
Simulation studies by Volkova et al. (2012) have 
predicted that the survival of resistant commensal 
bacteria in between antimicrobial doses in livestock 
can be expected. However, maintenance of resist-
ance would be dependent on bacteria- and plas-
mid-specific biological and ecological factors, and 
on the prevalence of resistant bacteria in the host 
and in the environment (da Costa et al., 2013).
The same issues have been discussed in hu-
mans carrying resistant strains and undertaking 
antimicrobial therapy (da Costa et al., 2013, PHE, 
2014). In Escherichia coli, transfer of resistance 
determinants between bacteria has been mainly 
associated with the selection pressure imposed by 
AMU (da Costa et al., 2013). Use of β-lactams has 
been associated with increased levels of MRSA 398 
strain isolated in livestock through a co-selection 
mechanism (ECDC/EFSA/EMA, 2009).
Use of third-generation cephalosporins in live-
stock has been associated with emergence and 
spread of ESBLs in Gram-negative bacteria, which 
poses a serious risk to public health (Aarestrup 
et al., 2008). The sporadic isolation of carbapen-
em-resistant Gram-negative bacteria in livestock 
is also deemed a serious risk to public health, as 
carbapenems are considered “last-resort” β-lact-
am antimicrobials for therapy of life-threatening 
infections in humans. Carbapenems are not cur-
rently used in food-producing animals and are 
predominantly used in human hospital settings 
(Table 4). Nevertheless, there could be a risk of 
co-resistance through use of other antimicrobials 
in agriculture or through horizontal transfer from 
human pathogens (EFSA, 2013). Transfer of resist-
ance traits within the bacterial cell can be induced 
by AMU and has been observed with macrolides 
in Enterobacteriaceae. Erythromycin promotes the 
transposition of erythromycin-resistant genes from 
a non-conjugative to a conjugative plasmid, which 
can then become mobile between bacteria (Cour-
valin, 2008). In contrast, in countries where use 
of particular substances (e.g. fluoroquinolones) is 
discouraged in livestock, low levels of, or no resist-
ance to, these antimicrobials are observed in food-
borne zoonotic pathogens (Aarestrup et al., 2008).
Antimicrobials at low dosages (i.e. residual lev-
els, sub-lethal or sub-therapeutic dosages) are also 
factors contributing to resistance as they promote 
genetic and phenotypic variability in exposed bac-
teria (Andersson and Hughes, 2014, You and Sil-
bergeld, 2014, Martinez, 2008), even though they 
are less likely to kill susceptible bacteria – leading 
to selection bias – than antimicrobials adminis-
tered at higher dosages. In addition, sub-lethal dos-
ing also appears to increase gene expression, devel-
opment of virulence and formation of biofilms that 
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Antimicrobial class
Hazard of zoonotic 
relevance 
Probability 
of AMR transfer
Carbapenems and other penems Enterobacteriaceae High
Ceftaroline and ceftobiprole (e.g. fosfomycin) MRSA Low
Glycopeptides •	 Enterococcus spp.
•	 MRSA
High
Glycylcyclines •	 Enterobacteriaceae
•	 MRSA
Low
Lipopeptides •	 Enterococcus spp.
•	 MRSA
Low
Monobactams •	 Enterobacteriaceae High
Oxazolidinones •	 Enterococcus spp.
•	 MRSA
High
Penicillins (carboxypenicillins and  
ureido-penicillins including beta-lactamase  
inhibitors combinations)
•	 Enterobacteriaceae
•	 Enterococcus spp.
High
Riminofenazines None specific Low
Sulfones None specific Low
Drugs used solely to treat tuberculosis  
or other mycobacterial diseases
None specific High
Source: adapted from EMA, 2014
Table 4. Antimicrobial groups currently not licensed for veterinary use in the eU
are also indirectly responsible for resistance due to 
the close proximity of bacteria, which may favour the 
horizontal transfer of mobile resistance determinants 
(Andersson and Hughes, 2014, Lupo et al., 2012).
Soil (Mathew et al., 2007, Forsberg et al., 2012) 
and water (Lupo et al., 2012) bacteria have been 
described as reservoirs for resistance genes, and 
are exposed to antimicrobial residues derived from 
human, industrial, and agricultural use (Forsberg et 
al., 2012) (Figure 5). Persistence of resistant bacteria 
and resistance genes in the farm environment and 
in medicated feed has been associated with acqui-
sition of resistance by enterococci bacteria isolated 
from livestock and poultry and it is currently a ma-
jor public health issue (da Costa et al., 2013, You 
and Silbergeld, 2014, IFT, 2006, Acar and Moulin, 
2012). Presence of antimicrobial residues derived 
from anthropogenic, industrial and agricultural us-
age in the aquatic and terrestrial environments also 
contribute to selection pressure on environmental 
bacteria (Lupo et al., 2012, Forsberg et al., 2012, 
You and Silbergeld, 2014) and commensal and 
pathogenic bacteria present in the gut microbiota of 
farmed animals (You and Silbergeld, 2014). It must 
be noted that antimicrobials differ in how efficiently 
they are processed in animal guts (and thus in the 
volume of residue excreted) (Kemper, 2008), and in 
how long the residues remain bioavailable in the en-
vironment (e.g. how quickly they are adsorbed to 
soil) (Kumar et al., 2005, Kemper, 2008). Therefore 
different antimicrobials pose different levels of pub-
lic health risk (AAM, 2009). For example, sulphona-
mides do not strongly adsorb to soil, thus remaining 
bioavailable in the environment for relatively long 
periods (Wegst-Uhrich et al., 2014). Excretion rates 
are dependent on the type of antimicrobial, mode 
of administration, animal species and period since 
administration. Excretion rates for tetracyclines and 
sulphonamides may vary between 40 and 90 per-
cent, for example (Kemper, 2008). There is currently 
a lack of data on concentrations of antimicrobials 
in soil, manure and surface water, perhaps due to 
insufficiently sensitive analytical methods (Thanner 
et al., 2016). Importantly, antimicrobials which are 
concentration-dependent, such as fluoroquinolones 
and aminoglycosides, are more likely to rapidly exert 
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selection pressure on bacteria in soil or water before 
they are diluted, in comparison to time-dependent 
antimicrobials (such as macrolides and β-lactams) 
which require sustained high concentrations in order 
to have an effect on bacterial viability (Amábile-Cue-
vas, 2016).
The growing prevalence of MDR organisms ena-
bles coselection, hence requiring the removal of all 
antimicrobials in order to achieve a useful reduction 
in the prevalence of resistance. However, reduction 
of numbers of resistant bacteria may only be possi-
ble if these are outnumbered by susceptible bacteria 
in an antimicrobial-free environment in which only 
a small number of individuals have been exposed to 
antimicrobials, or in the presence of a limited “se-
lection density” (Levy and Marshall, 2004). This will 
usually not be the case in high-selection-density en-
vironments such as hospitals and conventional in-
tensive farms (Levy and Marshall, 2004, PHE, 2014).
Antimicrobial growth promoters (AGPs)
Exposure of bacteria to sub-therapeutic concentra-
tions of antimicrobials is likely to have an impor-
tant role in AMR evolution (Andersson and Hughes, 
2014). The use of AGPs as feed additives in inten-
sively produced animals has been found to alter 
the gut microbiota of treated animals and promote 
resistance transfer within the animal and the envi-
ronmental microbiome (You and Silbergeld, 2014). 
AGPs are administered at sub-therapeutic dosages 
to groups of animals via drinking water or feed for 
prolonged periods to improve growth rates (Wielin-
ga et al., 2014, Capita and Alonso-Calleja, 2013, 
Castanon, 2007). AGPs are sold and used in many 
countries without veterinary prescription or supervi-
sion (Laxminarayan et al., 2013). There is still con-
flicting evidence, however, as to whether the im-
provement in animal production due to the use of 
AGPs is significant, and the mechanism behind any 
such effect is still largely unknown (Lee et al., 2012). 
It is important to state that the impact of AGPs 
on productivity could be as little as 1 percent or 
lower, if nutrition, hygienic practices and health 
care of the herd or flock are also improved (Lax-
minarayan, 2015). However such necessary im-
provements may not always be easy to achieve, 
especially in LMICs, where resources are limited. 
The banning of AGPs in Europe in 2006 (Europe-
an Commission, 2005) led to a reduction in the 
levels of vancomycin-resistant enterococci (VRE) 
previously observed in poultry in Denmark (Singer 
et al., 2003). Vancomycin was not licensed for use 
in poultry, but resistance had emerged as result 
of the use of avoparcin (also a glycopeptide) as 
an AGP in poultry production (Singer et al., 2003, 
Wielinga et al., 2014). Even though sub-therapeu-
tic dosages have been linked to the emergence 
of antimicrobial resistance, AGPs continue to be 
used in many non-EU countries in intensive animal 
production, although the extent of this is currently 
unknown (Singer et al., 2003, Capita and Alon-
so-Calleja, 2013, Castanon, 2007). There has been 
a recent move in the United States to reduce their 
use (BVA, 2012). 
Animal feed is supplemented by other, non-an-
timicrobial compounds, which may, in turn, affect 
microorganisms. Sepiolite, for instance, has been 
used as an additive in animal feed since 1990 
in the EU. It slows the passage of food through 
the intestinal tract, enabling a better absorption 
of nutrients. Sepiolite is not an antimicrobial, nor 
does it exert any antimicrobial effect, but it does 
promote the horizontal transfer of resistance plas-
mids between bacteria, which could be aggra-
vated if there is concomitant presence of AGPs 
(Rodríguez-Beltrán et al., 2013). This is just one ex-
ample of the very complex and unpredictable inter-
actions made possible by the use of antimicrobials. 
Prophylaxis
This is defined as the administration of an antimi-
crobial to susceptible but healthy animals to pre-
vent the occurrence of infectious disease. A com-
mon example is the infiltration of the mammary 
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Figure 5. Antimicrobial usage in humans, animals and agriculture, and resulting dispersion  
of antimicrobial residues into aquatic and terrestrial environments (represented by red dots)
Source: Van Boeckel et al., 2014 
glands of dairy cattle with antimicrobials such as 
penicillins, cephalosporins, or other lactams after 
cessation of lactation (Landers et al., 2012, Capita 
and Alonso-Calleja, 2013). Such AMU is likely to 
have a similar effect to that of growth promoters, 
although therapeutic levels of dosing, if adhered 
to, should be less likely to induce resistance in ex-
posed bacterial populations.
 Nevertheless, this may not be the case when the 
administration occurs in animal groups through 
water and feed (e.g. pigs, poultry) due to the varia-
tions in consumption by individual animals and the 
number of animals exposed. It must also be noted 
that – particularly in countries where antimicrobi-
al production and storage chains are inadequate 
(due to environmental or infrastructure-related is-
sues) – antimicrobials may be susceptible to deg-
radation through oxidation-reduction reactions, 
hydrolysis, biodegradation or photodegradation 
(Osei Sekyere, 2014). These antimicrobial prepa-
rations may then have reduced concentration and 
bactericidal activity when used, allowing for the 
survival of exposed bacteria and the generation of 
resistance (Osei Sekyere, 2014).
In addition to the use of antimicrobials in live-
stock, tetracyclines have been used in honeybee 
Drivers, Dynamics anD epiDemiology of antimicrobial resistance in animal production
20
colonies since the 1950s in the United States to 
control infections by Melissococcus pluton and 
Paenibacillus larvae. The diversity of tet genes en-
coding either efflux pumps or ribosome protection 
has been detected at high levels in the microbiota 
of US honeybees, while only exceptionally in bees 
from countries where tetracyclines are not used 
(Tian et al., 2012).
Metaphylaxis
Defined as the administration of an antimicro-
bial at therapeutic doses to all animals within a 
group in which some individuals have exhibited 
infection. Metaphylaxis acts both as a treatment 
for those animals currently infected and a preven-
tive measure against infection in those animals 
who are healthy but risk becoming infected. The 
administration of oxytetracycline in the flock wa-
ter supply, as treatment and prevention against 
mycoplasma infections in poultry, is a common 
example. The number of animals exposed to 
metaphylaxis is often large: in poultry produc-
tion, medicated water or feed can be used to 
treat more than 30 000 birds in the same flock. 
In addition, even if precise dosing is used – for 
example where antimicrobials are administered to 
all members of a herd in injectable form – such 
widespread AMU inevitably increases the risk of 
resistance emergence, due to the increased prob-
ability of bacteria with natural resistance encoun-
tering the antimicrobial and potentially being se-
lected for within the affected microbiota. 
Therapeutic use
This describes treatment of active bacterial infec-
tion in a single animal, or a group, via antimicro-
bial administration. Whereas even a single dose of 
antimicrobial administered to a single animal has 
the propensity to generate AMR within bacterial 
populations resident in that animal, the repeated 
and continued usage of antimicrobials, for example 
to treat recurrent infections, compounds this risk 
(Usui et al., 2014, Harada and Asai, 2010). Often, 
broad-spectrum antimicrobials are used in livestock 
before, or in place of, a confirmed diagnosis (for ex-
ample before undertaking any antimicrobial suscep-
tibility testing) due to economic considerations. The 
administration of macrolide antimicrobials such as 
erythromycin to pigs, regardless of the route of ad-
ministration, has been shown to select for resistance 
in Campylobacter spp. strains (Harada and Asai, 
2010). The duration of systemic treatment should 
only be long enough to ensure elimination of infec-
tion in the affected animal or animal populations as 
this could result in further selective pressure on the 
gut microbiota (EMA, 2015). Correct dosing is very 
important for the reasons stated above. In addition, 
for antimicrobial substances that have been licensed 
for veterinary use for many years, recommend-
ed dosages by manufacturers in the Summaries of 
Products Characteristics (SPCs) may not always be 
adequate as these may have not been calculated 
in accordance with updated pharmacokinetics and 
pharmacodynamics principles, or may not have tak-
en account of the evolution of antimicrobial suscep-
tibility in bacterial populations (EMA, 2015).
It is important to note that when antimicrobials 
are administered via largely unregulated vehicles 
such as feed or water – whether for therapeutic, 
metaphylactic or prophylactic purposes – the ex-
act intake of individual animals will be hard to 
ensure and define, and sub-optimal dosing may 
occur (particularly of sick animals within a group 
housing and/or an ad lib feed and water system), 
increasing the risk of AMR emergence.
Biocide use
These are substances which, through chemical or 
biological action, hinder the activity of a broad spec-
trum of microorganisms (SCENIHR, 2009, IFT, 2006).
 Not only are they commonly used in agricul-
tural settings – their use is also frequent in hu-
man health-care systems and at community level. 
They may lead to emergence of AMR through 
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cross-resistance, co-resistance and clonal drift 
mechanisms, and by activating an SOS response 
in bacteria leading to the repair and integra-
tion of DNA, some of which may include resist-
ance genes (Capita and Alonso-Calleja, 2013, 
Davin-Regli and Pagès, 2012). Biocide use within 
the agricultural industry can be divided into two 
broad categories: a) animal feed preservatives 
and b) disinfectants and antiseptics. Within the 
food-production industry, biocides may also be 
used as food preservatives or decontaminants. 
Examples include sulphites, lactic acid, trisodi-
um phosphate or acidified sodium chlorate. Such 
compounds inhibit the growth of microorganisms 
in, or on, foodstuffs and produce (Capita and 
Alonso-Calleja, 2013).
Lower susceptibility and resistance to biocides 
has been reported in bacterial populations since 
the 1950s (Davin-Regli and Pagès, 2012). Plas-
mids, transposons and integrons often also carry 
genes conferring resistance to biocides (e.g. dis-
infectants and antiseptics) and to heavy metals, 
providing an evolutionary advantage to the resist-
ant bacteria even in the absence of antimicrobial 
pressure (Martinez and Baquero, 2009, Acar and 
Moulin, 2012). Resistance mechanisms are similar 
for biocides and antimicrobial substances: selec-
tion pressure from biocide use – in food produc-
tion, industrial, agricultural and human health 
care settings, and water and wastewater treat-
ment facilities – could result in cross- or co-se-
lection for AMR (Davin-Regli and Pagès, 2012, 
SCENIHR, 2009). Biocides and antimicrobial sub-
stances may share common target sites (SCENIHR, 
2009) and can be located closely together in mo-
bile units (e.g. plasmids), leading to co-resistance 
(Levy and Marshall, 2004). Efflux pumps coded 
at chromosomal level have been involved in re-
sistance to both antimicrobials and biocides (e.g. 
quaternary ammonium) due to their non-spe-
cific mechanism (Cambau and Guillard, 2012). 
Resistance to biocides has been associated with 
stress responses in bacteria, particularly when in 
the presence of sub-lethal doses but also in the 
presence of other stressors in the environment 
(e.g. osmotic and oxidative pressure, pH, nutri-
ent availability) (IFT, 2006). Non-compliance with 
recommended dilution, preparation and storage 
of biocides may explain the increased tolerance 
to these products at low or sub-lethal concen-
trations and changes in phenotypic expression 
(e.g. membrane permeability, changes in mem-
brane charge, efflux pumps, biofilm formation) 
of exposed bacterial populations (Davin-Regli and 
Pagès, 2012, SCENIHR, 2009). There is currently 
a paucity of data relating to the extent of biocide 
use, presence of environmental residues and en-
vironmental stability (SCENIHR, 2009). Although 
risk assessment for AMR occurrence due to expo-
sure to biocides is now a mandatory requirement 
for registration and licensing of these substanc-
es in European countries (Anon., 2012), there is 
still little information on the correlation between 
biocides and antimicrobial resistance (Oggioni et 
al., 2015).
Quaternary ammonium compounds or ethanol, 
for example, are used to destroy or inhibit micro-
organisms in animal husbandry and food produc-
tion and processing facilities. In a recent study, 
Listeria monocytogenes and Salmonella enterica 
strains exhibited reduced susceptibility to chlorine 
dioxide and peroxyacids when exposed to increas-
ing concentrations of these chemicals over time. 
In addition, the resistance of these bacterial spe-
cies to various antimicrobials also increased after 
disinfectant exposure. Prior exposure to acidic 
disinfectants also increased the percentage of 
L. monocytogenes bacteria surviving subsequent 
acid treatments (SCENIHR, 2009).
Despite several existing studies providing evi-
dence of a role of biocides in the emergence of 
AMR, exceptions exist where only weak or moder-
ate correlations were observed between phenotypic 
biocide resistance and AMR in some bacteria such 
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as Staphylococcus aureus (Oggioni et al., 2015). 
Therefore, further research is needed to assess the 
impact of biocides on pathogens relevant to public 
health. Since such substances are used ubiquitously 
and in large quantities throughout the food chain, it 
may be surmised that their relative impact on AMR 
emergence within agriculture and food industries 
may be important. Nevertheless, in order to quan-
tify further the repercussions of biocide use on the 
emergence of AMR within and outside the agricul-
tural industry, further in-field surveillance of biocide 
use, and research into potential causal associations, 
is warranted (Fraise, 2002). It must also be noted 
that the use of biocides is very widespread in many 
industries, and the disease burden to humans and 
domestic animals without their use would need to 
be weighed against any potential benefits from their 
reduced use.
Animal feed preservatives
Preservatives such as citric acid or sodium benzo-
ate protect animal feed against decay caused by 
microorganisms. Such organic acids when ingest-
ed by food-producing animals may induce a se-
lection pressure on gut bacteria (SCENIHR, 2009). 
In addition, these preservatives are often added in 
large quantities to feed such as silage, an increas-
ing trend globally. This silage, if stored in such a 
manner that effluent can contaminate the envi-
ronment, may potentially extend selection pres-
sure to environmental bacteria.
 
Heavy Metals
Heavy metals may be used in agriculture as part 
of livestock feed supplements, and in a Chinese 
study were detected in manure from pig farms 
(Zhu et al., 2013). Heavy metals have been asso-
ciated with the emergence and spread of AMR in 
environmental bacteria due to co-selection.
The presence of heavy metals has also been 
associated with the reduction of susceptibility of 
bacterial populations in soil (Aminov and Mackie, 
2007) and commensal bacteria (e.g. enterococ-
ci) (Werner et al., 2013) to antimicrobials. Heavy 
metals in soil could be derived from mining and 
industrial activities but also from agriculture and 
health care (e.g. mercury in dental amalgams) 
(Aminov and Mackie, 2007). AGPs used in live-
stock production can also contain heavy metals 
as trace elements (e.g. copper, zinc), or med-
ication (e.g. arsenic in coccidiostatics) (You and 
Silbergeld, 2014). These metals can co-select for 
AMR not only in the gut microbiota but also in the 
environment through their persistence in animal 
waste (You and Silbergeld, 2014). Commensals 
and pathogens in the gut microbiota of animals 
could also be exposed to heavy metals through 
contaminated feed (e.g. mercury in fishmeal) (De-
fra, 2014, You and Silbergeld, 2014).
Other potential sources of resistance 
emergence and maintenance
One hypothesis is that stress and resistance genes 
in the bacterial genome are located closely togeth-
er, which would promote their co-expression under 
stressful conditions, even in the absence of AMU 
(Mathew et al., 2007). Stressors identified as asso-
ciated with emergence and transfer of resistance 
include extreme temperatures and variations on os-
motic pressure and pH that could have an impact on 
the integrity of the DNA and affect bacterial survival 
(Aarestrup et al., 2008). Lack of biodiversity in eco-
systems – often due to human action – also seems to 
drive the emergence of resistance determinants and 
bacteria (da Costa et al., 2013). 
Transfer of resistant bacterial clones to hosts (i.e. 
humans and animals) is dependent on the age and 
health status of the host, and the frequency of con-
tacts between the host and the environment, and/or 
between humans and animals (Martinez and Baque-
ro, 2009, Mathew et al., 2007). Host stressors such 
as weaning have been described as influencing the 
prevalence of AMR as they might have an impact 
on the gut environment, either by enhancing uptake 
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of resistance genes by bacteria or by favouring the 
survival of resistant strains (Mathew et al., 2007). 
Finally, a number of stress conditions in urban areas, 
especially those in LMICs, have been related to the 
selection or maintenance of AMR genes in poten-
tially pathogenic bacteria (Rosas et al., 2011). Con-
ditions as apparently unrelated to antimicrobials as 
air pollution might foster the resistance of airborne 
bacteria to antimicrobials (Jiménez-Arribas et al., 
2001). 
Risks of agricultural antimicrobial usage, 
other than AMR selection
Antimicrobial usage of any kind implies a risk for 
AMR selection and spread. We currently lack ad-
equate risk-assessment models for exploring the 
impact of agricultural AMU, simply because we 
have a poor understanding of the complex pro-
cesses that lead to the emergence and spread 
of AMR. Many such mechanisms, e.g. mutations 
and horizontal transfer between distantly-relat-
ed bacteria, occur at very low rates, often below 
our detection capabilities. However, as bacterial 
populations are enormous and many of them 
still unknown (we have been able to culture less 
than 10 percent of the species of the human 
microbiota, and less than 1 percent of the soil 
microbiota), most of these very rare phenomena 
at individual organism level must be occurring 
frequently at population level. In addition, there 
are other unpredictable implications of AMU in 
livestock. Statutorily acceptable levels of oxytet-
racycline and erythromycin in meat, following use 
in food-producing animals, can disrupt the fer-
mentation process of sausages, as they are able 
to inhibit microbial starter cultures, but may allow 
the growth of pathogens such as S. typhimurium 
and Escherichia coli O157:H7 (Kjeldgaard et al., 
2012). 
This shows that the use of antimicrobials in 
food-producing animals may lead to food-related 
outbreaks through unexpected pathways.
AMR emergence and AMU  
within different animal 
production systems 
Aquaculture
Antimicrobials are widely used in aquaculture for 
therapeutic, metaphylactic and prophylactic pur-
poses. AMR in aquaculture can occur through di-
rect exposure to antimicrobials delivered as group 
therapy to fish, or through livestock and human 
effluents containing resistant bacteria, resistance 
genes and antimicrobial residues. These will then 
exert selection pressure on gut microbiota of fish 
and on other bacteria in the aquatic environment 
(FAO/OIE/WHO, 2006). The extent and persis-
tence of antimicrobial residues in these produc-
tion systems is currently unknown, but they are 
likely to be greatly diluted in the environment. 
The presence of antimicrobial residues in sea sed-
iment could be due to constant exposure of fish to 
medicated feed and antimicrobial group treatments 
(Muziasari et al., 2014). It is worth noting that no 
antimicrobial agents have ever been developed 
solely for fish or shellfish therapy, in part due to the 
difficult and expensive registration process for anti-
microbial drugs (Scarano et al., 2014, Rodgers and 
Furones, 2009). Therefore, the substances widely 
used in aquaculture are the same as those licensed 
for therapy and prophylaxis of infectious diseases in 
humans and livestock. 
These include commonly used drugs (Capita 
and Alonso-Calleja, 2013, FAO/OIE/WHO, 2006), 
including substances currently deemed as critical-
ly important in human medicine (Table 5).
Resistance determinants to commonly used an-
timicrobials such as fluoroquinolones, tetracyclines 
and florfenicol have been detected in aquatic bacte-
ria, some of which are also human pathogens such 
as Escherichia coli (Miranda et al., 2013). Resistance 
genes and bacteria resistant to sulphonamides and 
trimethoprim have also been isolated from the sedi-
ment under aquaculture farms in the Baltic Sea and 
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persisted in the environment for at least 6 years, 
however, there was no evidence of spread to nearby 
aquatic areas (Muziasari et al., 2014).
Nonetheless, these kinds of sediments could act 
as reservoirs of resistance genes and bacteria in lo-
cal fish farms and in humans via food distribution 
(FAO/OIE/WHO, 2006). Most marine bacteria cannot 
yet be cultured (Suzuki et al., 2013), therefore it is 
possible, although speculative, that there may be as 
yet undetected reservoirs of resistance in the aquatic 
environment.
 
Land-based intensive systems 
The intensification of livestock production (i.e. 
large numbers of animals kept at high density 
and usually indoors) has been associated with 
the use of antimicrobials as prophylaxis against 
infectious disease, often for prolonged periods 
and for large populations of animals. Pro- and 
metaphylactic use of antimicrobials at different 
stages of livestock production can also have an 
impact on the emergence of resistance (Salyers, 
2001). In Poland, higher levels of resistance have 
been reported in E. coli isolates in piglets. This 
contrasted with the predominant E. coli isolates 
with susceptible pheno- and genotypes reported 
in sows in the same study (Mazurek et al., 2013). 
It was associated with the prophylactic use of an-
timicrobials in younger animals to prevent and 
contain the spread of respiratory and gastrointes-
tinal infectious diseases (Mazurek et al., 2013).
Animals bred for intensive production also tend 
to have reduced variability in their microbiota and 
a similar susceptibility to colonization with par-
ticular bacterial species (Schokker et al., 2014). 
This, coupled with the close proximity of animals 
Antimicrobial
group
Antimicrobial  
substance
Route of  
administration
Importance to  
human medicine
Aminopenicillins Amoxicillin Oral Critically important
Ampicillin Oral Critically important
Amphenicols Chloramphenicol** Oral/Bath/Injection Highly important 
Florfenicol* Oral Highly Important
Macrolides Erythromycin Oral/Bath/Injection Critically important
Aminoglycosides Streptomycin Bath Critically important
Neomycin Bath Critically important
Nitrofurans Furazolidone Oral/Bath Important
Nitrofurantoin** Oral Important
Fluoroquinolones Oxolinic acid Oral Critically important
Enrofloxacin* Oral/Bath Critically important
Flumequine Oral Critically important
Tetracyclines Oxytetracycline Oral/Bath/Injection Highly important
Chlortetracycline Oral/Bath/Injection Highly important
Tetracycline Oral/Bath/Injection Highly important
Sulphonamides Sulphonamides Oral Highly important
* Licensed only for veterinary use.
** Banned for use in commercial aquaculture in most fish-exporting countries since 2002.
Critically Important for human medicine are those antimicrobials which meet both Criterion 1 and Criterion 2 (see below).
Highly Important are those antimicrobials which meet either Criterion 1 or Criterion 2. 
Important are those antimicrobials which meet neither Criterion 1 nor Criterion 2. 
Criterion 1. An antimicrobial agent that is the sole, or one of limited available therapies, to treat serious human disease.
Criterion 2. An antimicrobial agent used to treat diseases caused by either: a) organisms that may be transmitted to humans from  
non human sources or, b) human diseases causes by organisms that may acquire resistance genes from non human sources ( WHO 2012).
Table 5. Antimicrobial agents and classes used in aquaculture and their importance  
in human medicine
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in such systems, could result in amplification of 
any resistant population(s) of bacteria, which may 
outcompete other bacterial populations. Again, 
partially due to the factors above, an intensive 
system run with poor biosecurity and herd/flock 
health may run a high risk of being colonized by 
pathogenic strains of bacteria (Zhu et al., 2013).
Should poor animal health within such situa-
tions also necessitate the increased use of antimi-
crobials, this is likely to support the development 
of AMR (FAO, 2013b). Given ever-growing global 
demand for livestock products, it is expected that 
intensive production will continue to expand in 
the future. It may be hypothesized, however, that 
intensive systems with high biosecurity may, in 
fact, reduce requirements for AMU and thus re-
duce the risk of AMR emergence. Intensive farms 
may also be able to take practical steps to miti-
gate AMR transfer into and out of the system. But 
as the authors could find little evidence to sub-
stantiate these theories in the literature, further 
research is warranted.
It is important to note that, while hypotheses 
can be made about the effect of agricultural prac-
tices on the emergence of AMR in food animals, 
biological factors need to be considered in rela-
tion to the potential for transmission of resistance 
to human bacterial populations. A systematic re-
view by Lazarus et al. (2015) found that poultry 
appeared to be a more likely source for a pro-
portion of human ESCREC infections than other 
food-producing animals (Lazarus et al., 2015).
Genomic data “have demonstrated that hu-
man extraintestinal pathogenic E. coli and avian 
pathogenic E. coli share numerous virulence fac-
tors” (Johnson et al., 2007), and “resistant strains 
that are able to infect avian sources are also more 
likely to possess the cellular machinery required 
to infect humans” (Lazarus et al., 2015). Such 
findings are relevant from a public health per-
spective since the fractional proportion of poultry 
products consumed globally currently outstretch-
es any other protein source, and is projected to 
continue to do so (due both to increasing global 
demand and the efficiency of poultry feed con-
version, which surpasses that of other livestock) 
(FAO, 2013a). 
Land-based extensive systems 
Extensive livestock farming systems, typically 
characterized by low inputs generating low out-
puts (the converse of intensive systems) may po-
tentially require lower inputs of antimicrobials, 
and thus by default, result in lower rates of AMR 
emergence.
However, by comparison with intensive systems, 
extensive systems require higher animal numbers 
for the same output. The Indian smallholder dairy 
subsector is one example (FAO, 2013b). Extensive 
systems involving free-roaming animals in large 
numbers may exhibit high commensal and patho-
genic bacterial transmission rates and exposure to 
multiple bacterial species (including environmen-
tal species such as soil bacteria) which may not 
be as prevalent in intensive systems (FAO, 2013b). 
These factors may result in promoting the gener-
ation and transmission of AMR genetic material 
and bacterial populations.
 
Organic systems
Organic production systems in different countries 
can vary in the level of antimicrobial therapies al-
lowed. In Europe, restrictions exist in the number 
of therapeutic courses allowed and the duration of 
withdrawal periods (Anon., 2007). Pro- and meta-
phylactic use of antimicrobials is prohibited. Alter-
native therapeutic plans are encouraged, and use 
of antimicrobials is only permitted when necessary. 
Use of vaccines for disease prevention is per-
mitted and encouraged (Anon., 2007, Mazurek et 
al., 2013). Recent studies comparing AMR levels in 
livestock reared in organic versus conventional pro-
duction systems showed higher concentrations in 
the latter (Mazurek et al., 2013, Cui et al., 2005, 
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Holtcamp, 2011). In Poland, Mazurek et al. (2013) 
reported that resistant E. coli isolates were mainly 
observed in cows raised in barns in conventional 
farms rather than in cows having access to pasture 
and raised organically, with lower exposure to anti-
microbials (Mazurek et al., 2013). In another study 
in the United States, MDR Campylobacter spp. 
strains were detected in both antimicrobial-free 
and conventional pig farms. This is likely due to 
environmental reservoirs that could be a source 
of resistance genes and resistant bacteria (Quin-
tana-Hayashi and Thakur, 2012). 
The authors do suggest, however, that in a poor-
ly managed organic system, the drive to reduce 
AMU may lead to the administration of doses of 
antimicrobials below the minimum inhibitory con-
centration (MIC), leading to an increased selection 
pressure for AMR bacteria and/or recurrent infec-
tions or extensive onward transmission, requiring 
repeat treatment of single or multiple animals and 
instigating selection pressure for AMR. 
In addition, in organic systems where livestock 
production is integrated with an extensive and/or 
a free-range or outdoor farming model, access to 
AMR genes or bacterial populations via soil bacteria 
and effluent may result in a propensity for organ-
ic/extensively-produced livestock to harbour AMR 
comparable with conventionally produced or indoor 
animals. One study conducted on pigs, which was 
the first to document the isolation of ciprofloxa-
cin-resistant Campylobacter coli in the United States, 
is a case in point (Gebreyes et al., 2005). More com-
parative research is required on this topic, though it 
may be suggested that high biosecurity, high herd/
flock health and indoor, organic systems may poten-
tially induce and harbour relatively less AMR than 
others. Despite this, it should be noted that bioc-
ide treatment of organically-produced animal feed 
and human foods may still potentially induce AMR 
in the food chain. The indiscriminate use of biocides 
should therefore be discouraged (Davin-Regli and 
Pagès, 2012, Fernández Fuentes et al., 2014).
Risk factors for the emergence of AMR in 
agriculture at national and international 
level
It is important to highlight the fact that the extent 
and patterns of AMU in agriculture and other in-
dustries are likely to vary considerably between and 
within countries, due to the influence of various 
factors. These may include, but are not limited to:
•	 legislative framework and governance;
•	 financial status and stability;
•	 degree of international imports and exports;
•	 human resources: population size, education 
and expertise;
•	 culture;
•	 structure and organization of the various agri-
cultural production systems in use nationally. 
In many countries, particularly LMICs, there have 
been dramatic changes in agricultural systems in re-
cent years, driven by both increasing local demand 
and new and emerging trade opportunities (HBF, 
2014, Rushton, 2010, FAO, 2013a, FAO, 2013b, 
Otte et al., 2007). A growing global population and 
increasing wealth in emerging economies, for exam-
ple in China and India (O’Neill, 2001), has stimulated 
demand for animal protein and the development of 
global value chains (Otte et al., 2007). For example, 
new export opportunities for sub-Saharan Africa 
(USDA, 2014) have led to increased production and 
intensification of agricultural systems in the region, 
with most recent figures showing 2.5 percent an-
nual growth in total cereal production over the last 
decade, total meat production doubling in the last 
20 years, and egg and milk production also expand-
ing at rapid and sustained annual rates (FAOSTAT, 
2014). Globally, poultry production has been grow-
ing this century at around 3 percent per year and 
seems set to continue to grow as global diets and 
consumption patterns shift (FAO, 2013a). Fish pro-
duction by aquaculture has been rising over the last 
20 years, from 13 percent of total world fish supply 
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Figure 6. Aquaculture fish production by region
Source: Adapted from FAO, 2013a
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in 1990 to 40 percent in 2010 (FAO, 2013a). The 
growth of aquaculture has been most significant 
in Asia, especially China, and also in Latin America 
and Africa as shown in Figure 6. Aquaculture is a 
fast-expanding agricultural sector in many LMICs, 
and the unregulated use of antimicrobials in many 
of these countries poses serious risks of AMR de-
veloping and spreading at local and global level – 
the latter through international trade (Heuer et al., 
2009). However, the negative impact of detection of 
residues in seafood in international trade has led to 
improved practices and certification of aquaculture 
by national regulatory bodies and international cer-
tifying agencies. 
Changes to agricultural systems as a result of intensifi-
cation involve changes in livestock/fish numbers, feed 
type and quantity used, husbandry methods, and an-
imal density. All of these factors can influence disease 
dynamics (Otte et al., 2007), which in turn may drive 
changes in AMU. The extent of the impact on AMU 
depends on the attitude of veterinary practitioners 
and farmers towards use of antimicrobials within par-
ticular legislative and governance frameworks, and al-
ternative methods for maximizing animal productivity.
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Local and global mechanisms 
of spread
Both pathogenic and non-pathogenic resistant 
bacteria can be transmitted from livestock to hu-
mans via food consumption, or via direct contact 
with animals or their waste in the environment 
(Marshall and Levy, 2011). Fomites can also play 
an important role in the local and wider spread 
of resistant bacteria. In Denmark, farm-to-farm 
spread of multidrug-resistant Salmonella enteri-
ca serovar typhimurium DT204 has been closely 
studied, and shared farm equipment (e.g. ma-
chinery) was identified as an important route 
(Aarestrup, 2006). 
Any mechanism that helps spread bacteria has 
the potential to transfer resistant bacteria. Resist-
ance may also be conferred by the exchange of 
genetic elements between bacteria of the same or 
different strains or species, and such transfer can 
occur in any environment where resistant bacteria 
have the opportunity to mix with a susceptible bac-
terial population, such as in the human or animal 
gut, in slurry spread on agricultural soil, or in aquatic 
environments (Woolridge, 2012, Aarestrup, 2006, 
Baquero et al., 2008). An example of a framework 
in which resistance genes could spread from poultry 
production to humans is shown in Figure 7. If re-
sistance develops in environmental bacteria, this can 
create an animal or human health problem when 
such bacteria contaminate water, food crops or an-
imal feed, introducing the opportunity for bacterial 
mixing with commensal or pathogenic species in the 
animal or human gut (Aarestrup, 2006, Finley et al., 
2013, Marti et al., 2013). 
Risk pathways for the spread of AMR via 
the environment
Many antimicrobial preparations used for livestock 
are given orally so that antimicrobial residues ex-
creted in animal faeces have the potential to ex-
ert selection pressure on bacterial populations in 
soil or water (Woolridge, 2012, AAM, 2009), as 
shown in Figure 5. However, evidence is scarce as 
to how important this mechanism is in transfer-
ring resistance (Hong et al., 2011, McEwen, 2006, 
Novo et al., 2013, Woolhouse et al. 2015), and 
different antimicrobials have different fates in the 
environment (Kumar et al., 2005, Kemper, 2008, 
AAM, 2009). It must be considered that residues 
resulting from human treatment with antimicrobi-
als or from pharmaceutical manufacturing can also 
exert selection pressure on environmental bacteria 
(Igbinosa et al., 2011, Baquero et al., 2008, Finley 
et al., 2013, Wellington et al., 2013, Novo et al., 
2013). Indeed, effluent from drug manufacturing 
has been found to contain extremely high con-
centrations of antimicrobial residues, as previously 
reported in countries with large pharmaceutical 
industries such as India (Larsson et al., 2007, Sim 
et al., 2011, Mutiyar and Mittal, 2014, O’Neill, 
2015).
Water, including that treated for human con-
sumption, is an important vehicle for the spread of 
AMR. Water is not only directly consumed by hu-
mans and animals, but is used for irrigation of crops 
which are then consumed by humans or used as an-
imal feed (Finley et al., 2013) (Figure 5). Water can 
spread antimicrobial residues, resistant bacteria and 
resistance genes far and wide through the flow of 
natural water bodies and anthropogenic influenc-
Mechanisms of spread of 
antimicrobial resistance 
between animals and humans
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Figure 7. conceptual framework for the spread of AMr genes in a poultry production system
es such as irrigation. This is a significant concern in 
LMICs, where water has been shown to be a major 
route for transmission of pathogenic bacteria to hu-
mans (Wellington et al., 2013). Recreational water 
use has also been linked to exposure to AMR bacte-
ria (Leonard et al., 2015). 
It has recently been found that antimicrobial 
residues, AMR genes and bacteria can spread for 
some distance via airborne particulate matter from 
large cattle feedlots in semi-arid areas of the Unit-
ed States (McEachran et al., 2015). These areas are 
prone to soil scouring, dust formation and strong 
winds. Communities living nearby are therefore ex-
posed to antimicrobial residues, AMR bacteria and 
genes via direct inhalation of contaminated dust or 
deposition of particulate matter onto skin, food or 
water (McEachran et al., 2015). 
In different environments, the relative impor-
tance of livestock sources of antimicrobial residues 
and AMR genes versus human sources will vary 
and the overall contribution of livestock waste to 
such environmental transmission pathways still re-
mains unclear (AAM, 2009, Wellington et al., 2013, 
Marti et al., 2013). There are considerable gaps in 
current knowledge, in part because environmental 
sites such as flowing watercourses are difficult to 
study due to their dynamic nature and of water’s 
diluting effect (Woolridge, 2012). Human sources 
of contamination in the environment make it diffi-
cult to ascertain the contribution of livestock pro-
duction to the environmental spread of AMR. While 
several studies from various regions have linked the 
presence of resistance in the environment with con-
tamination by waste from livestock or aquaculture 
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(effluent, wastewater, or manure), such transmission 
pathways are necessarily inferred rather than prov-
en (Woolridge, 2012, Binh et al., 2007, Acar and 
Moulin, 2006, Zhao et al., 2010, Hong et al., 2011, 
Heuer et al., 2002, Heuer and Smalla, 2007, Quin-
tana-Hayashi and Thakur, 2012, Li et al., 2012). 
According to a recent review by Luby et al. 
(2016), the vast majority of environmental bacteria 
cannot be cultured using current methods. Howev-
er, novel molecular techniques may be able to help 
fill these knowledge gaps. Metagenomics (the study 
of genetic material recovered from microbial com-
munities) and whole genome sequencing (WGS) 
are emerging techniques which can provide more 
detailed characterization of environmental micro-
biomes and therefore greater insight into the role 
of the environment as a reservoir of AMR (Penders 
et al., 2013, Schmieder and Edwards, 2012). AMR 
genes and other targets of interest such as path-
ogenicity islands or transposons can be identified 
from sequencing results, and quantified using pub-
licly available online databases such as the Com-
prehensive Antibiotic Resistance Database project 
(CARD) (McArthur et al., 2013), although databases 
are still not yet well-populated (Luby et al., 2016). 
One advantage is that the presence of AMR genes 
can be viewed within the broader context of the 
whole environmental microbiome – for example 
analysis of HGT markers can provide information 
on how AMR may have spread into an environment 
(Luby et al. 2016). Metagenomics has also been 
used to assess the efficiency of sewage treatment 
in removing AMR genes (Yang et al., 2014). Several 
high-income countries are currently adopting and 
developing metagenomics and WGS techniques to 
support their surveillance efforts, particularly in the 
monitoring and detection of bacterial strains rele-
vant to public health, and the carriage and diver-
sity of resistance genes within these. WGS allows 
the characterization of the full resistance genotype 
while WGS applied to RNA allows investigation of 
expression of resistance genes in bacterial isolates 
(Chan, 2016). There is still room for improvement of 
the methodologies, as well as a need for better bi-
oinformatics to combine and analyse the sequence 
data (Clausen et al., 2016). Molecular techniques 
are becoming more affordable for routine use in 
high-income countries, but the cost is still prohib-
itive for most LMICs.
Risk pathways for the spread of AMR  
via food distribution
As a consequence of the inherent challenges as-
sociated with data collection on environmental 
spread, food-borne transmission often becomes 
the primary focus for studies of livestock-to-human 
spread of AMR (Woolridge, 2012). Meat contam-
ination is undoubtedly easier to study, so there is 
some bias in favour of researching this transmission 
route. As a result, there is a considerable body of 
evidence describing the food distribution network 
as a risk pathway for transmission and spread from 
animals to humans. In Kenya, E. coli isolates from 
retail beef samples were found to be resistant to 
ampicillin (31 percent), tetracycline (20 percent) 
and nalidixic acid and ceftazidime (4 percent), with 
27 percent showing multidrug resistance (Kariuki 
et al., 2013). In the United States, the latest report 
on contamination of retail meats highlights cepha-
losporin resistance levels being above 2002 levels, 
while AMR levels in Salmonella from retail chicken 
were reported at 20 percent (a reduction from 38 
percent in 2009 and 28 percent in 2012) (NARMS, 
2013). MDR  Salmonella  was detected in all retail 
meat sources, although the proportion of MDR iso-
lates declined between 2011 and 2013. Ceftriax-
one resistance in E. coli isolates from retail chicken in-
creased from 8 percent in 2002 to 13 percent in 2011. 
Any food contaminated with resistant bacte-
ria provides a direct route for human colonization 
(Hong et al., 2011, Marti et al., 2013). Capita and 
Alonso-Calleja (2013) assert that, in quantitative 
terms, transmission of AMR via food is likely to be 
the most important known pathway from livestock 
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to humans (although it should be recognised that 
transmission via the environment – to which hu-
mans are continually exposed – is still poorly un-
derstood and has not yet been quantified). Trade in 
food products and human travel could have signif-
icant roles in the spread of AMR, both locally and 
globally. In a globalized world, people and prod-
ucts are transported around the earth in a matter 
of days, and AMR bacteria and resistance genes 
are disseminated with them. This has been demon-
strated in a number of studies of imported meat, 
fish and dairy products (Ozawa et al., 2002, Skov et 
al., 2007, Wilson, 2003, Noor Uddin et al., 2013, 
Zhao et al., 2003, Warren et al., 2008, Hong et 
al., 2011). Higher incomes in the emerging econ-
omies, the changing demands of consumers, and 
improvements in transportation technology mean 
that perishable foods, including animal-derived 
products, are now more easily shipped around 
the world than ever before (Aarestrup, 2006). As 
a consequence, strains of resistant bacteria can 
quickly reach areas where they had previously been 
uncommon or unknown (Okeke et al., 2005). The 
global trade in food products is expected to keep 
increasing in future, both in terms of volume and 
geographical coverage.
Despite convincing evidence for the existence of 
potentially important risk pathways for food-borne 
transmission of AMR, direct evidence for AMR in 
humans resulting from consumption of food prod-
ucts is very limited. This may be in part because 
hygiene procedures during meat processing can 
be very effective at removing bacteria. In a study 
of cattle from three beef feedlots in Nebraska, 
Schmidt et al. (2015) detected third-generation 
cephalosporin and trimethoprim-sulfamethoxa-
zole-resistant E. coli on 100 percent of hides but 
only 0.5 percent of carcasses and 0 percent of 
retail meat from the same animals. According to 
Wielinga et al. (2013), concern about the use of 
avoparcin as an AGP arose in Denmark during the 
1990s due to some evidence of a link to vanco-
mycin resistance in humans. Use of vancomycin in 
European hospitals was low, but levels of resistance 
in humans were high. Studies involving vegetarians 
and non-vegetarians showed a prevalence of about 
20 percent vancomycin-resistant enterococci (VRE) 
among meat eaters while none were detected in 
vegetarians. There are still considerable knowledge 
gaps around the risk of AMR emergence in humans 
associated with the consumption of animal-derived 
foods, and further research is urgently required.
The effect of low concentrations of antimicro-
bial residues on the human gut microbiome has 
also still to be elucidated. The Codex Committee 
on Residues of Veterinary Drugs in Foods (CCRVDF) 
recommends Maximum Residue Limits (MRLs) for 
veterinary drugs in foods. The Codex MRL is the 
maximum concentration of residue recommended 
as legally permissible or recognized as acceptable in 
or on a food. It is based on “the type and amount 
of residue considered to be without any toxicolog-
ical hazard for human health as expressed by the 
Acceptable Daily Intake (ADI) […] It also takes into 
account other relevant public health risks as well 
as food technological aspects […] Furthermore, the 
MRL may be reduced to be consistent with good 
practices in the use of veterinary drugs and to the 
extent that practical analytical methods are availa-
ble” (Codex Alimentarius, 2015a). 
A number of studies in Africa have reported 
unacceptably high antimicrobial residues in poul-
try meats (Dipeolu and Alonge 2002, Muriuki et 
al., 2001). A cross-sectional study of retail pork in 
suburban and urban districts in Hanoi, Vietnam, 
found that 5.5 percent of all meat samples from 
retail shops contained tetracycline residues (Duong 
et al., 2006). In China, 7.7 percent of aquatic food 
products were found with levels of residues that 
were unacceptable for human consumption (Hao 
et al., 2015). Recently, emerging evidence suggests 
that even very low concentrations of antimicrobial 
residues in foods could potentially alter the AMR 
characteristics of human intestinal bacteria. This 
Drivers, Dynamics anD epiDemiology of antimicrobial resistance in animal production
32
is, however, a complex and novel field of research, 
and there are still few studies addressing this im-
portant issue (Cerniglia et al., 2016). The amount 
of residues available to bacteria in the human gut 
is greatly affected by dose, the extent of binding 
to gut contents, and metabolism (Cerniglia et al., 
2016). It should be noted that while there are 
international guidelines for MRLs in food (WHO, 
2008, Codex Alimentarius, 2015b), there are no 
water quality guidelines regarding the presence of 
resistant bacteria or antimicrobial residues in fresh 
water used for human and animal consumption or 
crop irrigation. 
The application of manure to crops intended for 
human consumption is a possible pathway for the 
spread of AMR from animals to humans (Kumar et 
al., 2015, Tang et al., 2015). However, Marti et al. 
(2013) found that resistant bacteria on vegetables 
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grown for human consumption were ubiquitous 
regardless of farming system or geographical lo-
cation, thought to be due to the naturally-occur-
ring and ancient presence of AMR in soil bacteria. 
Furthermore, manuring the soil did not increase 
the prevalence of resistant bacteria on vegetables 
sold for consumption. Higher levels were detected 
when vegetables were harvested from soil where 
manure was still present, indicating that the peri-
od between application and harvesting could be 
optimized and is a critical control point.
Diverse opportunities for spread
Pathways of environmental and food-borne 
spread of AMR are complex and varied. Figure 8 
illustrates the diversity of interactions at the in-
terface between agriculture, humans, the envi-
ronment and wildlife through which the spread 
of AMR bacteria, resistance genes, or antimicro-
bial residues can potentially occur. The relative 
importance of each pathway in terms of risk is 
not demonstrated in Figure 8 due to the fact that 
many of these are still ambiguous, based on cur-
rent knowledge.
The vast majority of AMR spread is not moni-
tored or studied and thus the importance of trans-
mission pathways and the magnitude of spread is 
largely unknown. For example, resistance to syn-
thetic and semi-synthetic antimicrobials has been 
recently detected in faecal samples from mon-
keys, tapirs and felids in wild habitats of southern 
Mexico, the source(s) and transmission pathways 
of which are as yet unknown (Cristobal-Azkarate 
et al., 2014). As 70 percent of emerging zoonotic 
diseases originate in wildlife (Jones et al., 2008), 
the presence in wildlife of resistance to critical-
ly important antimicrobials is a significant public 
health concern. 
Clearly, there are diverse opportunities for envi-
ronmental spread of AMR as well as the perhaps 
more straightforward risk pathways of food distri-
bution. It should also be noted that some of the 
pathways shown in Figure 8 can operate at global 
as well as local level, and that many pathways op-
erate in multiple directions. For example, there are 
pathways from humans to food animals as well as 
vice versa, creating complex feedback loops.
Relevance and influence of 
animal production on the 
spread of antimicrobial 
resistance
International trade
Recent changes in the global patterns of trade in 
agricultural products have influenced the patterns 
of spread of bacteria and therefore the spread of 
AMR around the world (Finley et al., 2013, Aare-
strup, 2006). Major exporting countries are at risk of 
increased resistance acquisition due to the pressure 
to intensify agriculture to produce greater yields for 
export. On the other hand, international trade de-
mands could potentially foster more prudent use of 
antimicrobials in exporting countries. For example, 
good aquaculture practice certifications have been 
put in place in several LMICs as a result of import 
rejections in international markets due to detection 
of antimicrobial residues (FAO, 2012, FAO, 2011). 
Emerging economies rapidly opening up significant 
new markets become substantial importers of agri-
cultural products and potentially import new bacte-
ria with resistance genes selected for by the antimi-
crobials used in the country of export. 
Global trade patterns are shifting due to in-
creased demand and investments in agriculture. Af-
rica as a whole is a net importer of meat and dairy 
products, while Latin America is a significant export-
er of meat products, mostly from Brazil. Asia overall 
still imports considerably more meat and milk than it 
exports, however China is a now major exporter of 
meat products and fish while also importing a con-
siderable amount of meat, fish and dairy products. 
Thailand and India are major exporters, while Viet-
nam is a significant importer of meat products. Both 
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Thailand and Vietnam export a considerable amount 
of fish. Europe as a whole is a major importer and 
exporter of livestock products, while Australia and 
New Zealand are net exporters of meat, fish and dairy 
products (FAO, 2013a, FAO, 2014). The emerging 
economies of Brazil, Russia, India, China and South 
Africa (BRICS) are likely to contribute to changing 
global trade patterns. In emerging economies, there 
is likely to be an increase in AMU to secure produc-
tivity and ensure animal health in order to keep pace 
with the rapid expansion into new global markets.
There is thus an opportunity for increasing spread of 
AMR around the world in terms of both prevalence 
of AMR and diversity of resistance genes.
Aside from the potential global spread of AMR 
via trade in food products, live animals are also 
traded on an international scale for breeding and 
slaughter purposes, and this may also represent an 
important transmission pathway. While the numbers 
of animals moved around the globe may not com-
pare to the vast scale of the trade in food products, 
live animals are carrying large amounts of bacteria 
in their intestinal tract, which are continually mixing, 
exchanging genetic material and being excreted. In 
comparison with the amount of bacteria found on 
the surface of traded meat products, this animal mi-
crobiome represents a considerably higher contami-
nation risk. Breeding animals are usually introduced 
to importing countries at the top of a breeding pyr-
amid and thus have the potential to spread AMR to 
a large number of other farms (Aarestrup, 2006). 
While breeding animals are generally subjected to 
more rigorous health checks than live animals traded 
for slaughter, it is not known whether such checks 
routinely include testing for AMR.
Animal feed is also traded around the globe, and 
Salmonella spp. has often been detected in import-
ed feed, especially where it is produced in LMICs or 
contains animal proteins (Hsieh et al., 2014, Aare-
strup, 2006). A significant amount of water from 
shrimp farms is shipped along with shrimp in frozen 
blocks, transported from farms directly to interna-
tional consumers. This water can contain antimi-
crobial residues and AMR bacteria (Carvalho et al., 
2013, Reboucas et al., 2011, Zhang et al., 2011, 
Holmström et al., 2003, Le and Munekage, 2004), 
which may then come into contact with kitchen sur-
faces, other foodstuffs, and consumers themselves, 
enabling the global spread of bacteria and resist-
ance genes.
It is important to note that the legislative environ-
ment in each country – along with the strength of 
institutions to achieve widespread compliance – will 
influence the risk of emergence and spread of AMR 
within exporting countries and thereby influence the 
risk of international spread (FAO, 2014).
Influence of different types of agricultural 
systems on AMR spread
The type of agricultural system and basic infrastruc-
ture and services also influences the risk of ani-
mal-human-environmental transmission of patho-
gens at a more localized level, and these factors vary 
widely from country to country (FAO, 2013b). 
Intensive production systems will mean frequent, 
localized contact between livestock and humans in-
volved with production or living in the area (Rushton, 
2010) – and increased risk for transfer of AMR genes 
and resistant bacteria between animals, humans and 
the environment (Van Boeckel et al., 2015, Wardyn 
et al., 2015). Intensive livestock systems produce 
large quantities of waste, much of which is disposed 
of on nearby land, potentially increasing the risk of 
transfer of AMR genes to bacteria in the environ-
ment and to pathogenic or commensal bacteria in 
wildlife (Otte et al., 2007, Hong et al., 2011). Many 
large-scale intensive systems import animal feed and 
breeding stock on a global scale (Rushton, 2010), po-
tentially introducing novel strains of pathogenic and 
non-pathogenic resistant bacteria, which can then 
mix with the existing microbial communities in the 
intensive farm. Animal waste from these systems can 
also spread these resistant bacteria and resistance 
genes locally to farm workers, who then take them 
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into their community (Wardyn et al., 2015), and via 
manure and slurry spreading to the surrounding 
environment. In low-income settings, many work-
ers on intensive farms are also smallholder farmers 
themselves, while poultry from intensive systems are 
frequently sold at live bird markets (Rushton, 2010). 
This opens up opportunities for spread of AMR from 
intensive systems into local communities. In the fu-
ture, if production systems across the world continue 
to move towards intensification, the environmental 
spread of AMR may become a more important route 
than is currently perceived (Aarestrup, 2006). Animal 
products from intensive farms, and local crops grown 
using their manure, are likely to be destined for ex-
port or wide domestic distribution.
Smallholder systems also have inherent risk path-
ways for the spread of AMR, but of a different na-
ture. AMU by smallholders is likely to be less than in 
larger, more intensive farms, but it is also likely to be 
less controlled. Drugs may not be quality-assured, 
dosages may not be optimized and in some systems 
antimicrobials are more likely to be used without vet-
erinary supervision (Katakweba et al., 2012). In in-
tensive farming, inputs and outputs are closely man-
aged to maximize gain and little is avoidably wasted. 
The cost of antimicrobial treatment is offset against 
gains in animal health and the growth rate of ani-
mals. In smallholder systems, antimicrobials may be 
used less efficiently (Suriyasathaporn et al., 2012), 
which may result in increased excretion of antimicro-
bial residues into the environment. Sub-optimal dos-
es or inappropriate drugs can drive selection for re-
sistant bacteria within the animal gut, leading to the 
increased presence of resistant bacteria in livestock 
waste. In smallholder systems, animals are common-
ly in frequent and close contact with humans and 
wildlife, and often have freedom to roam and graze 
among animals from neighbouring farms or among 
human dwellings. AMR can therefore spread be-
tween farms and from livestock to humans. Wildlife 
grazing on shared land may be at increased risk of 
colonization with resistant bacteria via animal fae-
ces. If resistant bacteria are transferred to humans 
within these systems, they can spread readily and 
become endemic within the local community. The 
food distribution risk from smallholder systems in 
LMICs is considerable as animals may be slaughtered 
and butchered outside of abattoirs and without any 
formalized food-safety controls. However, meat and 
other animal products are typically consumed locally, 
often by the owners of the livestock themselves, so 
that the spread of AMR may remain limited to local 
communities. Some smallholders may sell produce 
at local markets, and this provides potential for more 
widespread dispersal. Inadequacies in biosecurity 
controls at live animal markets in LMICs can mean 
that bacteria, and therefore AMR, are transferred 
easily between animals and humans within the mar-
ket environment (Cardona et al., 2009). Compared 
with intensive systems, the global biomass of ani-
mals raised in smallholder systems is likely to be far 
less and therefore the volumes of antimicrobial resi-
dues and resistant bacteria excreted are also likely to 
be lower, meaning that there is arguably less trans-
mission into the environment overall from these sys-
tems. However, smallholder systems are numerous 
and ubiquitous in all countries and most ecological 
zones, and therefore provide the potential for resist-
ant bacteria to spread into diverse environments. 
In agro-ecological systems, where the environment 
may historically have had low exposure to AMR, the 
potential transfer of AMR into the environment is of 
particular concern. 
Medium-sized farms present a different set of 
risk pathways. They are typically small businesses 
or family-run operations, and contribute consid-
erably to global food security. AMU is likely to be 
less closely monitored and regulated than in inten-
sive systems, and antimicrobials may therefore be 
used in a less controlled way. Biosecurity controls, 
especially in pig and poultry farms, are likely to be 
much less strictly applied than in intensive systems. 
Although the volume of waste produced from these 
systems is much lower than from intensive systems, 
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waste disposal is likely to be less tightly regulated so 
that manure and slurry may be disposed of inappro-
priately (such as in nearby watercourses), or inade-
quately treated before disposal. Medium-sized farms 
are more likely than smallholder farms to sell animal 
products across large distances, perhaps through a 
marketing and distribution network, and may export 
some of their produce internationally. The intrinsic 
risk of AMR emergence in these systems, coupled 
with the potential for wide distribution, means that 
these systems are of concern in terms of their ability 
to spread AMR.
In LMICs, there are likely to be few or no 
waste-treatment facilities. Adelowo et al. (2014) ex-
plain that farming systems in Nigeria often dispose 
of waste by dumping, meaning that the local en-
vironment and freshwater supply can become con-
taminated with resistant bacteria and antimicrobial 
residues. Similarly, contamination of the environ-
ment with human sewage can also be a major fac-
tor in spreading AMR bacteria and genes to both 
humans and animals. The pathways of AMR transfer 
in such systems are likely to be complex and mul-
ti-directional, involving feedback loops between hu-
mans and animals.
Aquaculture in LMICs often features an in-
tegrated system which uses domestic farm and 
poultry waste as fish feed (Suzuki and Hoa, 2012). 
Antimicrobial residues or resistant bacteria from 
animal husbandry are therefore continuously intro-
duced into aquatic systems and may contribute to 
a reservoir of resistance genes in fish farms, as has 
been found in Tanzania and Pakistan (Shah et al., 
2012). Farmed fish are an important global food 
source, and in China, the world’s largest producer 
of farmed fish, the industrialization of production 
is leading to increasing use of antimicrobials. Fur-
thermore, resistance to the older antimicrobials 
such as tetracycline has led to increasing usage 
of quinolones, which are critical in human med-
icine. High levels of plasmid-mediated quinolone 
resistance (PMQR) genes have been found in aq-
uaculture systems in China, higher than in swine, 
poultry or human isolates (Jiang et al., 2012). The 
selection pressure of large quantities of antimi-
crobial residues in water can lead to the spread 
of resistance among aquatic bacteria. Novo et 
al. (2013) found that tetracycline residues in ur-
ban wastewater were significantly associated with 
higher prevalence of resistance, although not just 
resistance to tetracycline. This highlights the com-
plexity and gaps in our knowledge concerning the 
mechanisms of transmission within aquatic envi-
ronments. Muziasari et al. (2014) found few AMR 
genes in the environmental sediments below Baltic 
Sea fish farms, where there was no influence from 
human or agricultural systems, concluding that se-
lection pressure in this environment was minimal. 
The impact of aquaculture practices on the spread 
of resistance in aquatic systems remains largely un-
known, however, and evidence-gathering is com-
plicated by a variety of factors. For example, stud-
ies in both China and Egypt have also found ESBL 
genes in aquaculture systems which are attributed 
to pollution of these systems with human sewage 
(Jiang et al., 2012, Ishida et al., 2010).
We need to know much more about the im-
pact, in different types of agricultural production 
systems, of the use of antimicrobials on the spread 
of AMR into the environment (Rushton et al., 
2014), and in particular we lack data from LMICs 
(Adelowo et al., 2014).
Further spread of 
antimicrobial resistance:  
can it be stopped?
The consequences of the recent dramatic global 
changes in food consumption, international trade, 
agricultural production systems, and human trav-
el in terms of AMR spread and circulation are as 
yet scarcely known. The recent emergence and 
spread of colistin resistance in animals, food and 
humans at international level reflects this (Figures 
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2 and 3). If the selection pressure imposed by the 
use of antimicrobials was completely removed 
this would not necessarily stop the circulation of 
AMR. This is an “easy to get and hard to lose” 
problem according to Salyers et al. (1997), be-
cause resistance is very difficult to reverse due to 
the ability of genetic transfer elements to adapt 
to new hosts and new environments (Aminov and 
Mackie, 2007). Österblad et al. (2001) explain 
that restrictions on AMU are still extremely use-
ful, however, because the prevalence of resist-
ance found in wild animals is still low in areas 
where the use of antimicrobials in agriculture has 
historically been low. This indicates that the re-
lease of AMR genes into the environment may be 
an important point for intervention in controlling 
the spread of AMR (Aminov and Mackie, 2007). 
Antimicrobial residues in the environment are 
not monitored in the same way as are other haz-
ardous substances, e.g. the Dangerous Substances 
Directive 2006/11/EC (European Commission, 2006) 
in the European Union. Thus their concentration in 
the environment is likely to be underestimated or 
unrecognized. Antimicrobials are often large and 
complex molecules which biodegrade and behave 
differently to the archetype chemicals typically used 
in predictive models of environmental fate (Berkner 
et al., 2014). Some antimicrobials are not readily bi-
odegradable and may persist at high concentrations 
for long periods so that future development of more 
biodegradable antimicrobials might help to reduce 
the risk of environmental spread and circulation 
(Wellington et al., 2013). 
There is also a need for novel strategies of water 
quality improvement (Lupo et al., 2012). A con-
siderable amount of research has been conducted 
into the improvement of waste water treatment 
due to concerns over pharmaceuticals with unde-
sirable effects on wildlife, such as contraceptives 
or painkillers. Improving the ability of waste wa-
ter treatment plants to remove these pollutants 
would also help to lower environmental concen-
trations of antimicrobials with similar molecular 
size, particularly in aquatic environments. Swit-
zerland is one country that has already adopted 
such strategies (Berkner et al., 2014).
While the environmental proliferation of AMR 
is becoming increasingly recognized as an im-
portant control point, efforts to mitigate AMR 
spread have largely focused on food distribution 
until now, due to the more significant knowledge 
base regarding risk pathways and the fact that 
controls are easier to implement in food distribu-
tion systems. Strategies that minimize the risk of 
hazardous food-borne bacteria spreading, such 
as hygiene measures during slaughter and meat 
processing, and following “Hazard Analysis and 
Critical Control Point” (HACCP)  protocols, help 
to reduce such risk (Schmidt et al., 2015, WHO, 
2014b). Hsieh et al. (2014) showed that the pres-
ence of Salmonella spp. in animal feed could be 
reduced by monitoring and identifying critical 
control points at the stages in processing where 
control could be most effectively applied, recom-
mending standardized control procedures for an-
imal feed processors. Unfortunately, the present 
situation in LMICs of high AMU combined with 
inadequate resources and infrastructure to en-
sure rigorous hygiene during slaughter and meat 
processing does present significant challenges. It 
would also be advantageous to reduce or cease 
completely the transportation of live animals for 
breeding purposes, as it is possible instead to 
trade in embryos or semen, thereby avoiding the 
transportation of large numbers of bacteria in an-
imal guts (Aarestrup, 2006).
Given our current limited knowledge of trans-
mission pathways, options to mitigate the global 
spread of AMR involve controlling its emergence in 
various environments, and minimizing the opportu-
nities for AMR to spread along what may be the 
most important routes. There are clearly numerous 
opportunities for AMR to spread at local and global 
scale, and there are still large knowledge gaps as to 
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what the most important routes are. 
Mitigation strategies are indeed possible, and re-
quire a joint approach based on agricultural, medi-
cal and environmental interests. (Wellington et al., 
2013). The WHO draft Global Action Plan (GAP) for 
AMR draws attention to the use of good sanitation, 
hygiene and other infection prevention methods to 
curb the initial emergence and spread of AMR, these 
being important in mitigating the circulation of AMR 
in agriculture, humans and the environment (WHO, 
2014b). The Codex Alimentarius Code of Practice to 
Minimize and Contain Antimicrobial Resistance pro-
vides guidance on the responsible and prudent use 
of antimicrobials in food animals. The FAO Technical 
Guidelines for aquaculture certification (FAO, 2011) 
provide a framework for countries to implement 
regulated and responsible use of antimicrobials in 
aquaculture.
Because livestock, humans and the environment 
are intimately connected, it is important to consid-
er the emergence and spread of AMR from a “One 
Health” perspective, which provides a framework 
for an interdisciplinary approach to dealing with this 
enormous challenge (Finley et al., 2013, Robinson 
et al., 2016).
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Finally, we present a set of specific recommendations 
to address the knowledge gaps highlighted in this 
technical paper:
•	The extent of transfer of resistance genes 
between bacteria in the gut environment of 
humans and animals should be investigated 
to quantify the impact of AMU on bacterial 
populations.
•	The dynamics and interactions of genes and 
microbes within microbiota, microbiomes and 
different scales of microbial ecosystems, and 
the transfer of resistance within those, need to 
be better understood. This will require use of 
data generated by molecular techniques such 
as metagenomics together with epidemiological 
data in an integrated analysis. Databases of 
molecular sequences are expected to improve 
over time as usage increases, and bioinformatics 
techniques need to be developed in order to 
keep pace with the data challenges associated 
with the outputs of emerging new sequencing 
techniques.
•	Antimicrobial resistance genes and ICEs can 
be horizontally transferred between different 
microbial ecosystems. Being able to better predict 
the emergence and spread of resistant bacterial 
clones in the environment and human-agriculture 
interfaces will help to inform risk-assessment and 
management strategies. Molecular sequencing 
and epidemiological studies of resistant bacteria 
and resistance determinants are required 
to support risk assessment and simulation 
(modelling) studies. 
•	Standardized approaches should be used 
to create databases of resistance genes and 
mobile elements encoding resistance traits, and 
information should be shared freely, such as via 
the EU project COMPARE (COMPARE, 2015).
•	Pharmacodynamic and pharmacokinetics studies 
are required to assess how antimicrobials interact 
with microbial populations, particularly in the 
context of treatment of infections, in order to 
improve the efficacy of therapy and minimize 
the risk of AMR emergence. Studies involving 
sampling prior, during and post systemic 
antimicrobial exposure of livestock and aquatic 
animals are needed. This also should be applied 
to humans and to environments where contact 
between environmental, commensal and 
pathogenic bacteria is likely to occur  
(e.g. sewage). 
•	Changes in the human intestinal microbiome 
as a result of ingestion of low levels of 
antimicrobial residues in food can be studied 
using metagenomic and analytical chemistry 
approaches, in combination with bioinformatics. 
This will enable improved risk assessment for 
maximum residue limits in foods. 
•	The association between AMU on farms and 
AMR among food-borne bacteria, as well as 
the relationship between AMR in livestock and 
the incidence of resistant infections in humans, 
need to be quantified as a priority. This should 
include the direction and extent of transfer of 
resistance determinants and resistant strains 
occurring between and among animals, humans 
and the environment. There is an urgent need for 
improved data collection in this regard, especially 
from LMICS. In order to improve data collection 
there is a need for robust infrastructure and 
capacity – currently lacking in many countries – 
to monitor and investigate AMU and AMR.
•	Surveillance for AMR should include more 
emphasis on epigenetics (using molecular 
techniques and bioinformatics) to allow tracing 
the origin of emergence. Integrated surveillance 
should be conducted for AMU and AMR in food-
producing animals and humans. Furthermore, 
Recommendations
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AMR should also be assessed in food of both 
animal and non-animal origin. Wildlife species 
should be investigated as sentinels in surveillance 
programmes for resistance determinants and 
resistant bacteria in the environment. Further 
studies are needed to collect data on the extent 
and diversity of the resistance gene pool present 
in the environment. Priority should be given to 
the development of lab capacity and the training 
of veterinary and lab staff in LMICs to carry out 
novel molecular sequencing techniques, in order 
to support the establishment of AMR surveillance 
programmes in LMICs.
•	Selection pressure is observed even when 
antimicrobials are used responsibly, in compliance 
with current recommendations and guidelines. 
It is therefore important that the risk of AMR is 
assessed in the context of all antimicrobial usage 
practices, including usage that is compliant with 
legislation and recommendations. 
•	Antimicrobial residues in the environment should 
be monitored regularly in the same way as other 
hazardous substances.
•	Water treatment is an important control point for 
selection pressure and human/animal exposure. 
This aspect should be included in all strategies to 
reduce AMR risk.
•	Development of highly biodegradable 
antimicrobials should be prioritized in order 
to reduce the pressure of environmental 
contamination with antimicrobial residues. 
•	The use and misuse of biocides should be 
considered when assessing AMR risk. Further 
research is needed to assess the impact of 
biocides and heavy metals on AMR emergence 
in bacteria. Further in-field surveillance of biocide 
and heavy metal use, and research into potential 
causal relationships, is warranted.
•	 Intensive livestock production methods 
should be improved by identifying the most 
efficient systems with regards to minimizing 
environmental contamination with antimicrobial 
residues and resistant pathogens, taking into 
account local conditions and needs, and ensuring 
sustainability. The benefits of better feed, water, 
biosecurity and management standards need to 
be assessed. 
•	Epidemiologically and cost-effective hygiene 
practices must be applied within all farming 
systems and food sectors wherever possible 
to reduce human exposure to (resistant) 
pathogens. Use of HACCP protocols is strongly 
recommended in environments where food is 
processed and handled.
•	A “One Health” approach is essential to improve 
the efficiency of AMR research, surveillance, 
prevention and control systems. Harmonized 
responses and guidelines for AMU and AMR 
emergence investigation/tracing should be 
formulated with the integration of animal and 
human health systems and institutions. Using 
a “One Health” approach requires a deeper, 
interdisciplinary understanding of food systems, 
the drivers of human behaviour within these 
systems, and the factors which influence how 
society uses livestock. 
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APPENDIX 1
Review protocol
Study Question: Drivers, dynamics and epidemiolo-
gy of antimicrobial resistance in animal production: 
a critical review of the relationship between antimi-
crobial use in animal production (including aquacul-
ture) and AMR emergence and spread in animals 
and humans.
Review of the scope and effect of the 
issue of AMR in agriculture (PIO):
•	 Population = humans, livestock and fish or other 
aquatic species connected to animal production 
and food distribution.
•	 Issue = relationship between animal production 
practices and AMR emergence and spread and 
vice versa.
•	 Outcome = qualitative and quantitative categori-
zation of the role of animal production practices 
in AMR emergence and spread.
Search Strategy and Sources
As time and resources did not permit a systematic 
review of primary literature, the search strategy in-
volved identifying relevant reviews, reports and sec-
ondary literature via recommendations from global 
experts in the field of AMR. The list of references 
in gathered articles then lead to identification of 
further sources in specific areas where there were 
gaps (following initial review). It was recognized as 
important to include as broad a range of literature 
as possible and experts from a wide variety of insti-
tutions and countries in order to minimize the risk 
of bias in the gathering of literature.
Sources included:
•	 review articles (secondary literature);
•	 government, NGO and Private Agency Reports;
•	 raw data;
•	 grey literature;
•	 expert opinion, see Potential Collaborators Iden-
tified, below. 
Experts were contacted from:
•	 Australian National University, Australia;
•	 University of Guelph, Canada;
•	 European Medicines Agency, Belgium;
•	 Danish Institute for Food and Veterinary  
Research, Denmark;
•	 Technical University of Denmark, Denmark;
•	 University of Copenhagen, Denmark;
•	 Friedrich Loeffler Institute (FLI), Germany;
•	 Utrecht University, the Netherlands;
•	 Kenya Medical Research Institute (KEMRI), Kenya;
•	 Lusara Foundation, Mexico;
•	 Swedish National Veterinary Institute (SVA)
Sweden;
•	 SAFOSO AG, Switzerland;
•	 Royal Veterinary College, UK;
•	 Animal and Plant Health Agency, UK;
•	 Veterinary Medicines Directorate, UK;
•	 U.S. Department of Agriculture, USA.
Management of Search Results
All gathered literature was stored in EndNote 
reference management software. 
Inclusion/Exclusion Criteria
•	 Is the paper relevant to animal production 
(defined as the rearing of animals including 
aquatic species)?
•	 Does the paper relate to the study question?
•	 Is the article published or does it relate to work 
carried out within the last 15 years?
•	 Is the full text available for review?
•	 Is the paper available in English?
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Screening of Search Results
Based on the inclusion/exclusion criteria, one re-
viewer reviewed the title and abstract (or equivalent) 
of each article.
Data Extraction
A data extraction form was drawn up using specif-
ic headings corresponding to the population, issue 
and outcome (PIO), based on the study question. 
This facilitates continuity and reliability of data ex-
traction between researchers.
One reviewer extracted data from each article. 
Data were stored in a Microsoft Excel spreadsheet.
Data Quality Assessment
For each article the following was considered and 
documented:
a) Whether the study design or approach is appro-
priate to the research question, incorporating:
•	 whether the choice of outcome measure is valid 
and appropriate to the research question;
•	 whether there are any statistical issues in the 
analysis which may invalidate the study;
•	 whether the quality of reporting is adequate for 
incorporation within the technical paper;
•	 whether the study results are generalizable, 
within the remit of the technical paper.
b) The risk of bias in the study design/results.
Data Synthesis
The findings of individual eligible and quality-as-
sured studies were then collated, compared, con-
trasted, combined and summarized. These results, 
together with the associated interpretations and 
conclusions generated from narrative and quanti-
tative synthesis, and in accordance with the remit 
for the review, formed the technical paper.
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APPENDIX 2
Mechanisms of antimicrobial 
resistance to different 
antimicrobial groups
A very brief summary of resistance mechanisms is 
provided below (van Hoek et al., 2011):
The β-Lactams
Enzymatic inactivation: there are around 1000 
different β-lactamases known to date, some are 
only able to inactivate a few substances while oth-
ers can also inactivate third-generation cephalo-
sporins (extended-spectrum β-lactamases or ESBLs) 
and β-lactamase inhibitors (e.g. clavulanic acid). 
The β-lactamases are widely dispersed across bac-
terial groups, they can be chromosomal or plas-
mid-encoded. 
Acquisition of alternative pathways: as β-lactams 
inhibit several enzymes responsible for the synthe-
sis of bacterial cell walls (known as penicillin-bind-
ing proteins or PBPs), the acquisition of substitute 
enzymes can render a cell resistant to many, or all 
β-lactams. Altered PBPs are behind penicillin-re-
sistance in Streptococcus pneumoniae, acquired 
through transformation, either through accumula-
tion of repeated point mutations but also through 
recombination between PBP genes from related 
streptococci species (Chambers, 1999).
Aminoglycosides
Enzymatic inactivation: approximately 100 
acetyl-, phosphoryl-and nucleotidyl-transferases, 
which modify aminoglycoside molecules, rendering 
them inactive, have been reported. Most of these 
enzymes have a narrow spectrum (e.g. ANT(2’’)-I is 
only capable of inactivating gentamicin, tobramy-
cin and kanamycin). Nevertheless, the bifunction-
al phosphoryl- and acetyl-transferase – found in 
Gram-positive cocci – can inactivate most amino-
glycosides. Genes for these enzymes often reside in 
plasmids and transposons, and can be mobilized as 
gene cassettes between integrons. 
Modification of target: recently, 16S rRNA meth-
ylases that modify the ribosome hindering the bind-
ing of aminoglycosides, have been reported in en-
teric bacteria, Pseudomonas spp. and Gram-positive 
cocci. Also ribosomal mutations can render the ribo-
some insensitive to aminoglycosides.
Tetracyclines
Active efflux: around 30 tetracycline genes, e.g. 
tet(A, B, C, D, E, G, H, J, K), encode a tetracy-
cline-specific efflux pump, they are found both in 
Gram-positive and Gram-negative bacteria and are 
commonly encoded in transposons and integrons. 
Protection of target: approximately ten genes, e.g. 
tet(M, O, Q, S, T), encode ribosome protection pro-
teins that bind the ribosome, preventing the bind-
ing of tetracycline. In addition to enteric bacteria, 
these tet genes – particularly tet(M) are commonly 
found along macrolide resistance genes (see below 
‘Macrolides’ section) within the same transposon in 
Gram-positive cocci, and they can also be found in 
anaerobes. 
Macrolides
Modification of target: several erm genes encode 
a 23S rRNA methylase that modifies the ribosome, 
hindering the binding of macrolides. This modifica-
tion protects the ribosome from other chemically 
unrelated antimicrobials, such as lincosamides and 
streptogramins, hence called MLSB phenotype, a 
clear example of cross-resistance. The erm genes are 
often found in mobile genetic elements, erm(B) and 
tet(M) are both within Tn1545, a conjugative trans-
poson of streptococci.
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Active efflux: several mef genes encode a mac-
rolide-specific pump that reduces intracellular con-
centration of macrolides. Unlike erm genes, mef 
genes can only protect against macrolides, render-
ing an M phenotype.
Enzymatic inactivation: mph genes mediate inac-
tivation of macrolides, these genes are found mostly 
in Gram-negative bacteria, limiting their clinical rele-
vance. However, vat genes that also code for inacti-
vating enzymes, are found in Enterococcus spp. and 
Staphylococcus spp.
Quinolones
Modification of target: Mutations in gyr and/or 
par genes encoding gyrase and topoisomerase IV 
enzymes, respectively, allow for these enzymes to 
complete their three-step DNA supercoiling process, 
even in the presence of quinolones. A single muta-
tion can render a bacterial cell resistant to nalidixic 
acid, but two or more mutations are necessary to 
achieve resistance to fluoroquinolones (e.g. cipro-
floxacin, enrofloxacin). Although these mutations 
are recessive in nature, supposedly limiting their 
ability to be horizontally mobilized, transfer through 
transformation has been documented in streptococ-
ci, as the newly acquired gene substitutes the old, 
wild-type one via recombination.
Active efflux: although a ‘reserpine-sensitive’ efflux 
mechanism of quinolone resistance in pneumococci 
was reported, this phenotype is rather a multidrug re-
sistance one, mediated by unspecific efflux (see below).
Protection of target: a recently reported group 
of qnr genes encode a protein that protects topoi-
somerase enzymes from the action of quinolones. 
These genes, first reported as a unique plasmid-me-
diated quinolone resistance mechanism found in en-
teric bacteria, were then found in the chromosomes 
of many other organisms, along with related mdp 
genes of similar nature. These encode a low-level re-
sistance to quinolones, often below the breakpoints 
for full resistance in the clinical setting.
Enzymatic inactivation: recently, a modified 
aminoglycoside-resistance enzyme, AAC(6’)-lb-cr, 
has been found to be capable of inactivating cip-
rofloxacin. This enzyme is rather common in clinical 
isolates of enteric bacteria with reduced susceptibil-
ity to ciprofloxacin. 
Sulphonamides, trimethoprim
Acquisition of alternative pathways: sulphona-
mides inhibit dehydropteroate synthetase (DHPS) 
enzymes, while trimethoprim inhibits dihydrofolate 
reductase (DHFR) enzymes. By horizontally acquiring 
the genes for DHPS and/or DHFR variant enzymes 
that are not inhibited by these drugs, bacteria be-
come resistant. Of particular importance is gene 
sul/I, encoding one of such DHPS enzymes: this gene 
is part of the conserved region of class I integrons. 
Therefore, sulphonamides coselect for the entire ge-
netic element, along with whatever other resistance 
genes have been integrated into the integron and 
viceversa. 
Overproduction of target enzymes: mutants 
overexpressing DHPS and/or DHFR can overcome the 
inhibitory capacity of antifolate drugs at concentra-
tions reached clinically, and become resistant. 
Amphenicols 
Enzymatic inactivation: chloramphenicol acet-
yltransferase enzymes, encoded by a variety of 
cat genes, inactivate chloramphenicol rendering 
the producing bacteria resistant to the drug. The 
cat genes have been found in Gram-positive and 
Gram-negative bacteria alike. 
Modification of target: cfr genes encode for ribo-
somal methylase that modifies the ribosome so that 
florfenicol cannot bind, resulting in resistance. The 
clinical use of chloramphenicol is now very limited 
and florfenicol is now only used in veterinary set-
tings. Nevertheless, cfr genes are relevant to public 
health as the methylase produced also protects the 
bacterial ribosomes from the action of linezolid, an 
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oxazolidinone antimicrobial considered as a ‘last re-
sort’ drug against MRSA and VRE infections in hu-
mans. The cfr genes have been observed in linezol-
id-resistant clinical isolates worldwide.
Active efflux: cml and flo genes encode for spe-
cific efflux pumps, found mostly in Gram-negative 
bacteria.
Glycopeptides 
Modification of target: glycopeptides bind to 
terminal D-alanyl-D-alanine residues of cell wall 
pentapeptide precursors, blocking the following 
steps of cell wall synthesis (transglycosylation and 
transpeptidation). The van genes alter the pepti-
doglycan synthesis pathways so that, instead of 
Dala-D-ala, there is D-alanyl-D-lactate or D-ala-
nyl-D-serine. Clusters of van gene (five or more 
genes) are necessary to achieve glycopeptide re-
sistance, hence the whole cluster must be hori-
zontally transferred, likely through conjugation. 
Some van genes, probably originating from van-
comycin-producing organisms, were transferred 
to Streptomyces species and then into Gram-pos-
itive cocci.
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